This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Abnormal findings in nipple discharge synovial fluid wound secretions
R18_ABNORMAL_FINDI_NIPPLE_DISCH_SYNOVIAL_FLUID_WOUND_SECRE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
577 |
4. Check minimum number of eventsNone |
577 |
5. Include endpointsNone |
577 |
6. Filter based on genotype QC (FinnGen only) |
551 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R8[3-9]
- Name in latin
- Reperta abnormia in speciminibus ex aliis organis, systematibus et textibus
Similar endpoints
↥List of similar endpoints to
Abnormal findings in nipple discharge synovial fluid wound secretions
based on the number of shared cases.
Similar with more cases:
- Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 551 | 362 | 189 |
| Unadjusted period prevalence (%) | 0.11 | 0.13 | 0.09 |
| Median age at first event (years) | 54.10 | 51.74 | 58.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 577
- Matched controls
- 5770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R89.9
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, unspecified abnormal finding
3309.5
222.9
201
*
R89.1
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal level of hormones
+∞
131.4
121
*
R89.0
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal level of enzymes
+∞
112.2
104
*
R89.8
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, other abnormal findings
+∞
106.6
99
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
12.7
36.2
36
30
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
42.0
34.8
43
11
ULA02
NOMESCO Finland
Kolposcopy
5.4
25.2
52
104
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
24.1
146
613
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
20.9
313
1970
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
19.1
109
439
R4110
NOMESCO Finland
Physiotherapy
2.3
18.1
200
1095
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.7
17.5
109
459
Z2221
NOMESCO Finland
Medical doctor
2.2
17.2
196
1083
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
16.0
232
1400
ZXE00
NOMESCO Finland
One hour or less
2.1
15.5
254
1598
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
14.7
239
1493
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
14.7
68
243
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
13.9
73
280
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.0
13.7
65
235
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
11.3
13.1
24
22
A02BC02
ATC
pantoprazole; systemic
2.0
12.6
406
3138
WX402
NOMESCO Finland
General anaesthesia
2.1
12.6
153
852
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
12.3
210
1316
N02AX02
ATC
tramadol; systemic, rectal
1.9
12.3
264
1784
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
12.2
48
155
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
11.7
181
1094
R89.4
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal immunological findings
+∞
11.5
11
*
R89.6
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal cytological findings
+∞
11.5
11
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
15.4
11.4
18
12
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
11.0
34
94
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.1
10.8
45
151
Z3231
NOMESCO Finland
Registered nurse
1.9
10.7
172
1048
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
61.2
10.7
12
*
R89.7
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal histological findings
+∞
10.4
10
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
17.1
9.9
15
9
H02AB06
ATC
prednisolone; systemic
1.8
9.9
281
2026
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
9.9
48
176
N05CF01
ATC
zopiclone; oral
1.8
9.7
192
1245
AA1AD
NOMESCO Finland
CT of head and brain
1.8
9.5
170
1067
R89.5
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal microbiological findings
+∞
9.4
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
9.4
99
518
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.5
9.3
32
95
ZX120
NOMESCO Finland
Intravenous
2.4
9.2
64
281
B01AB05
ATC
enoxaparin; parenteral
1.8
9.2
186
1209
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
9.2
100
529
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.2
9.1
37
122
J01MA02
ATC
ciprofloxacin; systemic
1.7
9.1
219
1497
ZXD05
NOMESCO Finland
Urgent procedure
1.8
9.1
181
1172
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
9.0
153
944
K76.9
ICD-10 Finland
Liver disease, unspecified
7.0
8.9
21
31
C07AB07
ATC
bisoprolol; oral
1.7
8.7
268
1952
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.7
8.6
20
44
J01DB01
ATC
cefalexin; oral
2.0
8.6
481
4136
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
8.6
44
166
R4190
NOMESCO Finland
Nutritional therapy
3.2
8.5
34
111
TK800
NOMESCO Finland
Hemodialysis
5.0
8.4
18
37
R89.2
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal level of other drugs, medicaments and biological substances
+∞
8.4
8
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.8
8.3
25
68
XF402
NOMESCO Finland
ECG with work load test
2.3
8.2
67
316
J01FF01
ATC
clindamycin; systemic
1.8
8.2
162
1041
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.5
8.2
28
83
A11CC03
ATC
alfacalcidol; systemic
4.1
8.1
22
55
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
7.0
8.1
19
28
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
8.0
47
190
J01FA06
ATC
roxithromycin; oral
1.7
7.9
231
1648
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
7.9
127
766
N05BA04
ATC
oxazepam; oral
1.8
7.8
159
1028
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
7.8
61
282
A02BC05
ATC
esomeprazole; systemic
1.7
7.8
232
1662
ZXA00
NOMESCO Finland
Right side
1.8
7.8
150
956
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.4
7.7
19
44
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.6
130
798
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
7.6
61
286
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
7.6
35
125
A04
ICPC
Weakness/tiredness general
1.9
7.6
102
581
S29
ICPC
Skin symptom/complaint other
1.8
7.4
130
803
N05BA01
ATC
diazepam; systemic, rectal
2.0
7.4
84
451
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
7.4
79
415
Z3226
NOMESCO Finland
Physiotherapist
1.9
7.3
113
671
H02AB09
ATC
hydrocortisone; systemic
3.9
7.3
21
55
C03CA01
ATC
furosemide; systemic
1.7
7.3
157
1029
R89
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues
+∞
7.3
7
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
7.2
65
319
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
7.2
38
146
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
20.3
7.2
10
5
R06AE07
ATC
cetirizine; oral
1.6
7.1
256
1911
R50.9
ICD-10 Finland
Fever, unspecified
1.9
7.1
98
561
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
7.1
218
1566
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.5
7.0
17
39
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
7.0
92
519
B03XA02
ATC
darbepoetin alfa; parenteral
5.6
7.0
19
35
LDA10
NOMESCO Finland
Curettage of cervix uteri
7.7
6.9
15
20
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
6.9
100
583
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
6.8
119
733
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
16.9
6.8
10
6
H02AB04
ATC
methylprednisolone; systemic
1.9
6.7
88
496
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
6.7
65
329
D64.8
ICD-10 Finland
Other specified anaemias
5.6
6.7
18
33
A06AD11
ATC
lactulose; oral
1.9
6.6
83
461
N06AX21
ATC
duloxetine; oral
2.0
6.6
77
417
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.5
218
1592
C03DA01
ATC
spironolactone; oral
2.0
6.5
71
375
XF404
NOMESCO Finland
Ambulatory ECG
2.2
6.5
54
257
J02AC01
ATC
fluconazole; systemic
1.6
6.5
228
1685
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.5
6.4
41
174
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.5
6.3
21
61
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.9
6.3
18
47
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.6
6.2
36
145
N05CF02
ATC
zolpidem; oral
1.8
6.1
102
619
N02AA05
ATC
oxycodone; systemic
1.8
6.1
97
580
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.0
109
677
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
6.0
25
84
L04AA06
ATC
mycophenolic acid; systemic
4.0
6.0
17
44
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
9.5e-01
1.9e+00
3.4e+00
1.0e+50
3.4e+00
2.3e+00
7.8e-01
cases:4.70%
controls:1.86%
cases:4.35%
controls:0.64%
cases:2.43%
controls:0.09%
cases:2.61%
controls:0.00%
cases:2.44%
controls:0.09%
cases:5.43%
controls:0.58%
cases:5.44%
controls:2.56%
27
107
548
5643
25
37
550
5713
14
5
561
5745
15
0
560
5750
14
5
560
5741
30
33
522
5639
26
129
452
4907
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
1.0e+00
1.7e+00
2.8e+00
1.0e+50
3.5e+00
1.7e+00
1.1e+00
cases:13.04%
controls:5.10%
cases:11.13%
controls:2.28%
cases:5.57%
controls:0.35%
cases:4.52%
controls:0.00%
cases:7.32%
controls:0.23%
cases:11.23%
controls:2.17%
cases:15.69%
controls:6.10%
75
293
500
5457
64
131
511
5619
32
20
543
5730
26
0
549
5750
42
13
532
5733
62
123
490
5549
75
307
403
4729
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
1.3e+00
1.8e+00
3.0e+00
1.0e+50
2.9e+00
2.0e+00
9.1e-01
cases:6.78%
controls:1.95%
cases:4.17%
controls:0.71%
cases:2.09%
controls:0.10%
cases:0.87%
controls:0.00%
cases:2.09%
controls:0.12%
cases:4.89%
controls:0.71%
cases:6.07%
controls:2.52%
39
112
536
5638
24
41
551
5709
12
6
563
5744
5
0
570
5750
12
7
562
5739
27
40
525
5632
29
127
449
4909
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
1.3e+00
1.8e+00
3.0e+00
—
2.6e+00
1.9e+00
9.9e-01
cases:7.30%
controls:2.12%
cases:6.26%
controls:1.11%
cases:2.96%
controls:0.16%
—
—
cases:1.92%
controls:0.14%
cases:7.07%
controls:1.13%
cases:9.41%
controls:3.73%
42
122
533
5628
36
64
539
5686
17
9
558
5741
—
11
8
563
5738
39
64
513
5608
45
188
433
4848
Outpatient Visit
OP [9202]
OP [9202]
5.7e-01
9.0e-01
1.1e+00
5.3e+00
1.4e+00
1.3e+00
9.9e-01
cases:80.87%
controls:70.56%
cases:71.65%
controls:50.78%
cases:27.13%
controls:11.34%
cases:48.35%
controls:0.49%
cases:31.36%
controls:10.56%
cases:79.17%
controls:51.83%
cases:89.33%
controls:75.69%
465
4057
110
1693
412
2920
163
2830
156
652
419
5098
278
28
297
5722
180
607
394
5139
437
2940
115
2732
427
3812
51
1224
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
5.8e-01
1.0e+00
2.1e+00
3.8e+00
1.9e+00
1.1e+00
7.9e-01
cases:21.91%
controls:13.55%
cases:19.30%
controls:7.91%
cases:12.87%
controls:1.81%
cases:6.09%
controls:0.14%
cases:11.85%
controls:2.04%
cases:22.28%
controls:8.48%
cases:30.33%
controls:16.56%
126
779
449
4971
111
455
464
5295
74
104
501
5646
35
8
540
5742
68
117
506
5629
123
481
429
5191
145
834
333
4202
Hematology
82 [38004501]
82 [38004501]
1.1e+00
1.3e+00
1.8e+00
—
3.0e+00
2.1e+00
1.8e+00
cases:2.78%
controls:0.92%
cases:2.26%
controls:0.61%
cases:1.22%
controls:0.21%
—
—
cases:4.18%
controls:0.21%
cases:4.53%
controls:0.60%
cases:5.65%
controls:0.95%
16
53
559
5697
13
35
562
5715
7
12
568
5738
—
24
12
550
5734
25
34
527
5638
27
48
451
4988
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.6e+00
2.3e+00
2.6e+00
—
2.9e+00
1.7e+00
9.2e-01
cases:2.43%
controls:0.50%
cases:2.43%
controls:0.24%
cases:1.39%
controls:0.10%
—
—
cases:1.57%
controls:0.09%
cases:2.17%
controls:0.41%
cases:2.51%
controls:1.01%
14
29
561
5721
14
14
561
5736
8
6
567
5744
—
9
5
565
5741
12
23
540
5649
12
51
466
4985
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
1.2e+00
1.7e+00
2.9e+00
—
2.5e+00
1.8e+00
8.9e-01
cases:7.48%
controls:2.35%
cases:6.09%
controls:1.18%
cases:2.78%
controls:0.16%
—
—
cases:1.92%
controls:0.16%
cases:7.61%
controls:1.32%
cases:9.62%
controls:4.17%
43
135
532
5615
35
68
540
5682
16
9
559
5741
—
11
9
563
5737
42
75
510
5597
46
210
432
4826
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
1.5e+00
2.9e+00
—
—
2.8e+00
2.5e+00
1.3e+00
cases:4.00%
controls:0.96%
cases:5.22%
controls:0.31%
—
—
—
—
cases:1.39%
controls:0.09%
cases:3.26%
controls:0.28%
cases:5.86%
controls:1.71%
23
55
552
5695
30
18
545
5732
—
—
8
5
566
5741
18
16
534
5656
28
86
450
4950
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.1e+00
1.6e+00
2.9e+00
—
2.5e+00
1.7e+00
8.4e-01
cases:7.13%
controls:2.52%
cases:6.26%
controls:1.39%
cases:3.13%
controls:0.17%
—
—
cases:1.92%
controls:0.16%
cases:7.61%
controls:1.43%
cases:10.04%
controls:4.61%
41
145
534
5605
36
80
539
5670
18
10
557
5740
—
11
9
563
5737
42
81
510
5591
48
232
430
4804
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
4.0e-01
7.2e-01
2.0e+00
4.9e+00
1.8e+00
7.5e-01
3.0e-01
cases:33.91%
controls:25.67%
cases:33.22%
controls:19.50%
cases:24.17%
controls:4.00%
cases:17.22%
controls:0.16%
cases:20.21%
controls:4.14%
cases:34.24%
controls:19.75%
cases:42.05%
controls:35.07%
195
1476
380
4274
191
1121
384
4629
139
230
436
5520
99
9
476
5741
116
238
458
5508
189
1120
363
4552
201
1766
277
3270
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
4.2e-01
6.1e-01
2.0e+00
4.7e+00
1.7e+00
6.5e-01
3.3e-01
cases:33.04%
controls:24.57%
cases:31.30%
controls:19.86%
cases:23.13%
controls:3.76%
cases:13.39%
controls:0.14%
cases:18.64%
controls:3.92%
cases:32.97%
controls:20.43%
cases:43.31%
controls:35.52%
190
1413
385
4337
180
1142
395
4608
133
216
442
5534
77
8
498
5742
107
225
467
5521
182
1159
370
4513
207
1789
271
3247
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
1.0e+00
2.0e+00
3.2e+00
—
2.0e+00
1.4e+00
9.0e-01
cases:4.17%
controls:1.58%
cases:5.39%
controls:0.78%
cases:2.09%
controls:0.09%
—
—
cases:1.39%
controls:0.19%
cases:3.26%
controls:0.85%
cases:6.28%
controls:2.66%
24
91
551
5659
31
45
544
5705
12
5
563
5745
—
8
11
566
5735
18
48
534
5624
30
134
448
4902
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.0e+00
1.9e+00
3.2e+00
—
2.0e+00
1.4e+00
8.7e-01
cases:4.17%
controls:1.58%
cases:5.22%
controls:0.78%
cases:2.09%
controls:0.09%
—
—
cases:1.39%
controls:0.19%
cases:3.26%
controls:0.85%
cases:6.28%
controls:2.74%
24
91
551
5659
30
45
545
5705
12
5
563
5745
—
8
11
566
5735
18
48
534
5624
30
138
448
4898
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
8.2e-01
1.6e+00
2.8e+00
1.0e+50
2.3e+00
1.7e+00
1.1e+00
cases:6.26%
controls:2.87%
cases:7.65%
controls:1.63%
cases:3.83%
controls:0.24%
cases:3.48%
controls:0.00%
cases:3.14%
controls:0.33%
cases:7.43%
controls:1.50%
cases:11.92%
controls:4.13%
36
165
539
5585
44
94
531
5656
22
14
553
5736
20
0
555
5750
18
19
556
5727
41
85
511
5587
57
208
421
4828
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
1.0e+00
1.6e+00
2.6e+00
—
2.3e+00
1.6e+00
1.1e+00
cases:4.17%
controls:1.57%
cases:4.00%
controls:0.82%
cases:1.91%
controls:0.14%
—
—
cases:1.39%
controls:0.14%
cases:3.44%
controls:0.74%
cases:5.86%
controls:1.99%
24
90
551
5660
23
47
552
5703
11
8
564
5742
—
8
8
566
5738
19
42
533
5630
28
100
450
4936
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
1.0e+00
1.5e+00
2.7e+00
1.0e+50
2.7e+00
1.3e+00
9.2e-01
cases:5.04%
controls:1.90%
cases:3.83%
controls:0.85%
cases:2.09%
controls:0.14%
cases:1.22%
controls:0.00%
cases:2.26%
controls:0.16%
cases:3.99%
controls:1.15%
cases:6.07%
controls:2.50%
29
109
546
5641
22
49
553
5701
12
8
563
5742
7
0
568
5750
13
9
561
5737
22
65
530
5607
29
126
449
4910
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
9.0e-01
1.5e+00
2.7e+00
—
2.3e+00
1.5e+00
1.0e+00
cases:6.26%
controls:2.64%
cases:7.65%
controls:1.74%
cases:3.83%
controls:0.26%
—
—
cases:3.14%
controls:0.31%
cases:7.43%
controls:1.67%
cases:11.72%
controls:4.61%
36
152
539
5598
44
100
531
5650
22
15
553
5735
—
18
18
556
5728
41
95
511
5577
56
232
422
4804
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
5.1e-01
8.3e-01
1.6e+00
3.9e+00
1.7e+00
9.4e-01
6.0e-01
cases:15.48%
controls:9.91%
cases:11.30%
controls:5.29%
cases:7.30%
controls:1.51%
cases:4.87%
controls:0.10%
cases:7.67%
controls:1.57%
cases:12.32%
controls:5.20%
cases:17.99%
controls:10.76%
89
570
486
5180
65
304
510
5446
42
87
533
5663
28
6
547
5744
44
90
530
5656
68
295
484
5377
86
542
392
4494
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
8.0e-01
1.5e+00
3.0e+00
1.0e+50
2.9e+00
1.1e+00
6.8e-01
cases:7.30%
controls:3.43%
cases:6.09%
controls:1.46%
cases:4.00%
controls:0.21%
cases:3.13%
controls:0.00%
cases:1.92%
controls:0.10%
cases:4.53%
controls:1.62%
cases:8.16%
controls:4.31%
42
197
533
5553
35
84
540
5666
23
12
552
5738
18
0
557
5750
11
6
563
5740
25
92
527
5580
39
217
439
4819
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.0e-01
6.6e-01
2.0e+00
4.4e+00
1.8e+00
6.3e-01
4.7e-01
cases:37.74%
controls:30.96%
cases:30.43%
controls:18.40%
cases:19.30%
controls:3.29%
cases:14.78%
controls:0.21%
cases:16.55%
controls:3.25%
cases:30.98%
controls:19.22%
cases:49.58%
controls:37.97%
217
1780
358
3970
175
1058
400
4692
111
189
464
5561
85
12
490
5738
95
187
479
5559
171
1090
381
4582
237
1912
241
3124
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.3e+00
1.3e+00
2.2e+00
—
2.3e+00
1.8e+00
1.0e+00
cases:7.65%
controls:2.31%
cases:5.04%
controls:1.43%
cases:1.39%
controls:0.16%
—
—
cases:1.39%
controls:0.14%
cases:5.43%
controls:0.95%
cases:8.79%
controls:3.36%
44
133
531
5617
29
82
546
5668
8
9
567
5741
—
8
8
566
5738
30
54
522
5618
42
169
436
4867
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
1.2e+00
1.4e+00
2.3e+00
—
2.1e+00
1.7e+00
1.1e+00
cases:4.52%
controls:1.43%
cases:3.65%
controls:0.94%
cases:1.22%
controls:0.12%
—
—
cases:1.22%
controls:0.16%
cases:3.99%
controls:0.72%
cases:5.86%
controls:1.95%
26
82
549
5668
21
54
554
5696
7
7
568
5743
—
7
9
567
5737
22
41
530
5631
28
98
450
4938
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
2.7e-01
5.5e-01
2.0e+00
4.8e+00
1.7e+00
5.8e-01
3.2e-01
cases:34.96%
controls:29.13%
cases:33.04%
controls:22.12%
cases:23.65%
controls:4.00%
cases:16.00%
controls:0.16%
cases:19.51%
controls:4.33%
cases:32.97%
controls:21.65%
cases:46.44%
controls:38.68%
201
1675
374
4075
190
1272
385
4478
136
230
439
5520
92
9
483
5741
112
249
462
5497
182
1228
370
4444
222
1948
256
3088
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
9.9e-01
1.6e+00
2.5e+00
—
2.3e+00
1.3e+00
8.5e-01
cases:13.91%
controls:5.65%
cases:12.70%
controls:2.92%
cases:5.74%
controls:0.52%
—
—
cases:4.36%
controls:0.47%
cases:10.69%
controls:3.01%
cases:15.27%
controls:7.13%
80
325
495
5425
73
168
502
5582
33
30
542
5720
—
25
27
549
5719
59
171
493
5501
73
359
405
4677
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
8.2e-01
1.3e+00
2.7e+00
—
2.1e+00
1.5e+00
1.1e+00
cases:11.48%
controls:5.39%
cases:8.87%
controls:2.64%
cases:4.35%
controls:0.31%
—
—
cases:3.31%
controls:0.40%
cases:9.24%
controls:2.29%
cases:16.74%
controls:6.33%
66
310
509
5440
51
152
524
5598
25
18
550
5732
—
19
23
555
5723
51
130
501
5542
80
319
398
4717
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
2.2e-01
4.7e-01
1.9e+00
4.5e+00
1.5e+00
5.3e-01
4.6e-01
cases:37.22%
controls:32.24%
cases:33.22%
controls:23.76%
cases:22.26%
controls:4.23%
cases:13.91%
controls:0.17%
cases:17.07%
controls:4.23%
cases:34.42%
controls:23.62%
cases:54.18%
controls:42.65%
214
1854
361
3896
191
1366
384
4384
128
243
447
5507
80
10
495
5740
98
243
476
5503
190
1340
362
4332
259
2148
219
2888
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
1.2e+00
2.3e+00
—
—
2.5e+00
2.2e+00
1.2e+00
cases:3.83%
controls:1.22%
cases:6.43%
controls:0.71%
—
—
—
—
cases:2.09%
controls:0.17%
cases:4.35%
controls:0.51%
cases:6.90%
controls:2.16%
22
70
553
5680
37
41
538
5709
—
—
12
10
562
5736
24
29
528
5643
33
109
445
4927
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
9.6e-01
1.4e+00
2.5e+00
—
1.9e+00
1.5e+00
1.0e+00
cases:6.26%
controls:2.50%
cases:5.74%
controls:1.51%
cases:2.09%
controls:0.17%
—
—
cases:1.57%
controls:0.23%
cases:5.43%
controls:1.30%
cases:7.95%
controls:3.04%
36
144
539
5606
33
87
542
5663
12
10
563
5740
—
9
13
565
5733
30
74
522
5598
38
153
440
4883
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
2.2e-01
4.4e-01
1.9e+00
4.5e+00
1.5e+00
5.0e-01
4.5e-01
cases:37.04%
controls:32.14%
cases:32.52%
controls:23.60%
cases:21.91%
controls:4.16%
cases:13.74%
controls:0.17%
cases:16.03%
controls:4.12%
cases:33.33%
controls:23.33%
cases:53.56%
controls:42.32%
213
1848
362
3902
187
1357
388
4393
126
239
449
5511
79
10
496
5740
92
237
482
5509
184
1323
368
4349
256
2131
222
2905
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
7.9e-01
1.3e+00
2.4e+00
—
2.2e+00
1.4e+00
9.2e-01
cases:15.83%
controls:7.90%
cases:15.30%
controls:4.56%
cases:8.52%
controls:0.83%
—
—
cases:8.36%
controls:0.97%
cases:17.03%
controls:4.64%
cases:20.71%
controls:9.39%
91
454
484
5296
88
262
487
5488
49
48
526
5702
—
48
56
526
5690
94
263
458
5409
99
473
379
4563
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
7.7e-01
1.2e+00
2.7e+00
—
2.1e+00
1.4e+00
9.8e-01
cases:11.30%
controls:5.58%
cases:8.52%
controls:2.78%
cases:4.35%
controls:0.31%
—
—
cases:3.31%
controls:0.42%
cases:9.06%
controls:2.42%
cases:16.74%
controls:7.01%
65
321
510
5429
49
160
526
5590
25
18
550
5732
—
19
24
555
5722
50
137
502
5535
80
353
398
4683
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.9e-01
3.9e-01
1.8e+00
4.4e+00
1.5e+00
4.9e-01
3.4e-01
cases:39.48%
controls:35.04%
cases:36.35%
controls:27.86%
cases:25.57%
controls:5.25%
cases:14.96%
controls:0.23%
cases:20.21%
controls:5.52%
cases:38.41%
controls:27.56%
cases:55.65%
controls:47.14%
227
2015
348
3735
209
1602
366
4148
147
302
428
5448
86
13
489
5737
116
317
458
5429
212
1563
340
4109
266
2374
212
2662
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
1.4e+00
1.7e+00
—
1.0e+50
2.4e+00
1.7e+00
1.6e+00
cases:9.74%
controls:2.63%
cases:4.87%
controls:0.94%
—
—
cases:3.30%
controls:0.00%
cases:1.57%
controls:0.14%
cases:4.89%
controls:0.95%
cases:11.09%
controls:2.36%
56
151
519
5599
28
54
547
5696
—
19
0
556
5750
9
8
565
5738
27
54
525
5618
53
119
425
4917
Nephrology
39 [38004479]
39 [38004479]
1.3e+00
1.5e+00
2.3e+00
1.0e+50
2.3e+00
1.4e+00
9.7e-01
cases:3.13%
controls:0.90%
cases:2.26%
controls:0.52%
cases:1.57%
controls:0.16%
cases:0.87%
controls:0.00%
cases:1.57%
controls:0.16%
cases:2.72%
controls:0.67%
cases:2.72%
controls:1.05%
18
52
557
5698
13
30
562
5720
9
9
566
5741
5
0
570
5750
9
9
565
5737
15
38
537
5634
13
53
465
4983
Endocrinology
46 [38004485]
46 [38004485]
5.7e-01
1.3e+00
1.9e+00
1.0e+50
2.4e+00
2.1e+00
1.1e+00
cases:6.78%
controls:3.97%
cases:7.48%
controls:2.24%
cases:3.48%
controls:0.54%
cases:16.35%
controls:0.00%
cases:5.05%
controls:0.49%
cases:15.22%
controls:2.08%
cases:11.72%
controls:4.17%
39
228
536
5522
43
129
532
5621
20
31
555
5719
94
0
481
5750
29
28
545
5718
84
118
468
5554
56
210
422
4826
Internal Medicine
11 [38004456]
11 [38004456]
7.2e-01
1.2e+00
2.0e+00
—
2.2e+00
1.4e+00
1.0e+00
cases:34.43%
controls:20.31%
cases:22.43%
controls:7.98%
cases:8.70%
controls:1.30%
—
—
cases:10.80%
controls:1.29%
cases:25.36%
controls:7.70%
cases:34.31%
controls:16.18%
198
1168
377
4582
129
459
446
5291
50
75
525
5675
—
62
74
512
5672
140
437
412
5235
164
815
314
4221
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
8.3e-01
1.4e+00
2.0e+00
—
2.4e+00
1.1e+00
6.6e-01
cases:8.35%
controls:3.81%
cases:6.26%
controls:1.57%
cases:1.22%
controls:0.17%
—
—
cases:1.39%
controls:0.12%
cases:4.53%
controls:1.50%
cases:8.58%
controls:4.61%
48
219
527
5531
36
90
539
5660
7
10
568
5740
—
8
7
566
5739
25
85
527
5587
41
232
437
4804
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
8.0e-02
7.0e-01
9.6e-01
4.6e+00
1.1e+00
5.4e-01
5.5e-01
cases:17.04%
controls:15.95%
cases:11.65%
controls:6.17%
cases:3.48%
controls:1.36%
cases:8.00%
controls:0.09%
cases:3.48%
controls:1.17%
cases:10.51%
controls:6.42%
cases:21.13%
controls:13.42%
98
917
477
4833
67
355
508
5395
20
78
555
5672
46
5
529
5745
20
67
554
5679
58
364
494
5308
101
676
377
4360
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.9e-01
4.8e-01
1.8e+00
4.2e+00
1.4e+00
4.8e-01
2.5e-01
cases:38.61%
controls:34.26%
cases:34.61%
controls:24.73%
cases:21.91%
controls:4.40%
cases:7.83%
controls:0.12%
cases:14.63%
controls:4.18%
cases:34.24%
controls:24.28%
cases:52.09%
controls:45.75%
222
1970
353
3780
199
1422
376
4328
126
253
449
5497
45
7
530
5743
84
240
490
5506
189
1377
363
4295
249
2304
229
2732
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
5.9e-01
1.2e+00
2.5e+00
—
1.8e+00
1.3e+00
8.7e-01
cases:11.83%
controls:6.92%
cases:11.48%
controls:3.77%
cases:5.39%
controls:0.45%
—
—
cases:4.53%
controls:0.75%
cases:12.14%
controls:3.76%
cases:21.13%
controls:10.07%
68
398
507
5352
66
217
509
5533
31
26
544
5724
—
26
43
548
5703
67
213
485
5459
101
507
377
4529
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
6.7e-01
1.1e+00
2.5e+00
—
1.8e+00
1.2e+00
9.1e-01
cases:11.65%
controls:6.35%
cases:8.87%
controls:3.10%
cases:4.35%
controls:0.38%
—
—
cases:3.31%
controls:0.54%
cases:9.06%
controls:2.82%
cases:17.78%
controls:8.02%
67
365
508
5385
51
178
524
5572
25
22
550
5728
—
19
31
555
5715
50
160
502
5512
85
404
393
4632
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-4.7e-01
-3.1e-01
8.9e-01
—
2.9e+00
3.1e+00
2.7e+00
cases:21.04%
controls:29.98%
cases:5.91%
controls:7.88%
cases:1.22%
controls:0.50%
—
—
cases:1.92%
controls:0.10%
cases:7.07%
controls:0.35%
cases:14.64%
controls:1.13%
121
1724
454
4026
34
453
541
5297
7
29
568
5721
—
11
6
563
5740
39
20
513
5652
70
57
408
4979
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
6.5e-01
1.3e+00
2.3e+00
—
2.1e+00
1.1e+00
7.1e-01
cases:16.35%
controls:9.27%
cases:16.52%
controls:4.90%
cases:6.96%
controls:0.77%
—
—
cases:5.92%
controls:0.75%
cases:13.04%
controls:4.92%
cases:19.87%
controls:10.84%
94
533
481
5217
95
282
480
5468
40
44
535
5706
—
34
43
540
5703
72
279
480
5393
95
546
383
4490
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.8e+00
2.2e+00
—
—
—
2.2e+00
1.9e+00
cases:1.74%
controls:0.28%
cases:1.91%
controls:0.21%
—
—
—
—
—
—
cases:2.17%
controls:0.25%
cases:2.30%
controls:0.36%
10
16
565
5734
11
12
564
5738
—
—
—
12
14
540
5658
11
18
467
5018
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.4e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.3e-01
2.7e-01
cases:42.43%
controls:39.08%
cases:40.17%
controls:31.44%
cases:29.04%
controls:6.47%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.61%
cases:40.94%
controls:31.05%
cases:59.00%
controls:52.40%
244
2247
331
3503
231
1808
344
3942
167
372
408
5378
104
20
471
5730
128
380
446
5366
226
1761
326
3911
282
2639
196
2397
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.3e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.3e-01
2.8e-01
cases:42.43%
controls:39.18%
cases:40.35%
controls:31.53%
cases:29.04%
controls:6.49%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.63%
cases:40.94%
controls:31.01%
cases:59.21%
controls:52.40%
244
2253
331
3497
232
1813
343
3937
167
373
408
5377
104
20
471
5730
128
381
446
5365
226
1759
326
3913
283
2639
195
2397
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.3e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.3e-01
2.7e-01
cases:42.43%
controls:39.25%
cases:40.35%
controls:31.55%
cases:29.04%
controls:6.47%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.67%
cases:40.94%
controls:31.05%
cases:59.21%
controls:52.46%
244
2257
331
3493
232
1814
343
3936
167
372
408
5378
104
20
471
5730
128
383
446
5363
226
1761
326
3911
283
2642
195
2394
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.3e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.3e-01
2.7e-01
cases:42.43%
controls:39.25%
cases:40.35%
controls:31.58%
cases:29.04%
controls:6.49%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.65%
cases:40.94%
controls:31.06%
cases:59.21%
controls:52.46%
244
2257
331
3493
232
1816
343
3934
167
373
408
5377
104
20
471
5730
128
382
446
5364
226
1762
326
3910
283
2642
195
2394
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.3e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.3e-01
2.7e-01
cases:42.43%
controls:39.25%
cases:40.35%
controls:31.57%
cases:28.87%
controls:6.49%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.63%
cases:40.94%
controls:31.05%
cases:59.21%
controls:52.46%
244
2257
331
3493
232
1815
343
3935
166
373
409
5377
104
20
471
5730
128
381
446
5365
226
1761
326
3911
283
2642
195
2394
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.3e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.3e-01
2.7e-01
cases:42.43%
controls:39.29%
cases:40.35%
controls:31.62%
cases:29.04%
controls:6.52%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.67%
cases:40.94%
controls:31.08%
cases:59.21%
controls:52.52%
244
2259
331
3491
232
1818
343
3932
167
375
408
5375
104
20
471
5730
128
383
446
5363
226
1763
326
3909
283
2645
195
2391
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
8.8e-01
1.7e+00
3.0e+00
—
2.0e+00
1.4e+00
1.1e+00
cases:3.30%
controls:1.39%
cases:2.78%
controls:0.52%
cases:2.43%
controls:0.12%
—
—
cases:0.87%
controls:0.12%
cases:2.36%
controls:0.58%
cases:4.18%
controls:1.43%
19
80
556
5670
16
30
559
5720
14
7
561
5743
—
5
7
569
5739
13
33
539
5639
20
72
458
4964
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.4e-01
3.8e-01
1.8e+00
4.1e+00
1.4e+00
4.2e-01
2.7e-01
cases:42.61%
controls:39.29%
cases:40.35%
controls:31.55%
cases:29.04%
controls:6.50%
cases:18.09%
controls:0.35%
cases:22.30%
controls:6.68%
cases:40.76%
controls:31.03%
cases:59.21%
controls:52.50%
245
2259
330
3491
232
1814
343
3936
167
374
408
5376
104
20
471
5730
128
384
446
5362
225
1760
327
3912
283
2644
195
2392
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
5.0e-01
9.6e-01
2.0e+00
1.0e+50
2.8e+00
1.6e+00
6.4e-01
cases:7.30%
controls:4.57%
cases:5.57%
controls:2.21%
cases:1.74%
controls:0.24%
cases:1.22%
controls:0.00%
cases:2.61%
controls:0.16%
cases:8.15%
controls:1.75%
cases:9.00%
controls:4.96%
42
263
533
5487
32
127
543
5623
10
14
565
5736
7
0
568
5750
15
9
559
5737
45
99
507
5573
43
250
435
4786
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
4.8e-01
1.1e+00
2.2e+00
—
2.3e+00
1.3e+00
6.0e-01
cases:16.87%
controls:11.17%
cases:16.17%
controls:5.98%
cases:9.74%
controls:1.15%
—
—
cases:9.58%
controls:1.10%
cases:17.21%
controls:5.38%
cases:22.18%
controls:13.48%
97
642
478
5108
93
344
482
5406
56
66
519
5684
—
55
63
519
5683
95
305
457
5367
106
679
372
4357
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
7.0e-01
1.0e+00
2.8e+00
—
2.3e+00
1.1e+00
5.7e-01
cases:8.70%
controls:4.52%
cases:5.91%
controls:2.19%
cases:3.13%
controls:0.19%
—
—
cases:2.44%
controls:0.24%
cases:5.43%
controls:1.92%
cases:8.79%
controls:5.18%
50
260
525
5490
34
126
541
5624
18
11
557
5739
—
14
14
560
5732
30
109
522
5563
42
261
436
4775
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
6.6e-01
1.1e+00
2.2e+00
—
2.0e+00
1.2e+00
7.3e-01
cases:19.13%
controls:10.92%
cases:16.35%
controls:6.14%
cases:9.04%
controls:1.04%
—
—
cases:8.89%
controls:1.36%
cases:19.20%
controls:6.40%
cases:24.48%
controls:13.50%
110
628
465
5122
94
353
481
5397
52
60
523
5690
—
51
78
523
5668
106
363
446
5309
117
680
361
4356
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
6.7e-01
1.1e+00
2.2e+00
—
2.0e+00
1.2e+00
7.3e-01
cases:19.13%
controls:10.83%
cases:16.17%
controls:6.10%
cases:9.04%
controls:1.04%
—
—
cases:8.89%
controls:1.36%
cases:19.02%
controls:6.42%
cases:24.48%
controls:13.48%
110
623
465
5127
93
351
482
5399
52
60
523
5690
—
51
78
523
5668
105
364
447
5308
117
679
361
4357
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
6.6e-01
1.1e+00
2.2e+00
—
2.0e+00
1.2e+00
7.3e-01
cases:19.13%
controls:10.90%
cases:16.17%
controls:6.12%
cases:9.04%
controls:1.04%
—
—
cases:8.89%
controls:1.36%
cases:19.20%
controls:6.40%
cases:24.48%
controls:13.56%
110
627
465
5123
93
352
482
5398
52
60
523
5690
—
51
78
523
5668
106
363
446
5309
117
683
361
4353
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
6.4e-01
1.1e+00
2.2e+00
—
2.0e+00
1.2e+00
7.1e-01
cases:19.48%
controls:11.29%
cases:17.04%
controls:6.37%
cases:9.22%
controls:1.10%
—
—
cases:9.06%
controls:1.37%
cases:19.20%
controls:6.54%
cases:24.90%
controls:13.98%
112
649
463
5101
98
366
477
5384
53
63
522
5687
—
52
79
522
5667
106
371
446
5301
119
704
359
4332
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
5.5e-01
9.5e-01
2.4e+00
—
1.8e+00
1.2e+00
8.6e-01
cases:12.70%
controls:7.77%
cases:8.52%
controls:3.48%
cases:4.52%
controls:0.42%
—
—
cases:3.31%
controls:0.54%
cases:9.78%
controls:3.05%
cases:17.78%
controls:8.38%
73
447
502
5303
49
200
526
5550
26
24
549
5726
—
19
31
555
5715
54
173
498
5499
85
422
393
4614
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
6.5e-01
1.1e+00
2.2e+00
—
2.0e+00
1.2e+00
7.0e-01
cases:18.96%
controls:10.87%
cases:16.70%
controls:6.16%
cases:9.22%
controls:1.08%
—
—
cases:9.06%
controls:1.36%
cases:18.84%
controls:6.68%
cases:24.27%
controls:13.76%
109
625
466
5125
96
354
479
5396
53
62
522
5688
—
52
78
522
5668
104
379
448
5293
116
693
362
4343
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.9e-01
1.1e+00
2.2e+00
—
2.0e+00
1.2e+00
8.0e-01
cases:14.26%
controls:9.23%
cases:11.83%
controls:4.43%
cases:6.96%
controls:0.80%
—
—
cases:5.75%
controls:0.85%
cases:13.59%
controls:4.71%
cases:22.18%
controls:11.34%
82
531
493
5219
68
255
507
5495
40
46
535
5704
—
33
49
541
5697
75
267
477
5405
106
571
372
4465
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
1.1e+00
1.6e+00
—
—
3.1e+00
1.9e+00
7.8e-01
cases:2.78%
controls:0.97%
cases:1.91%
controls:0.38%
—
—
—
—
cases:1.92%
controls:0.09%
cases:2.36%
controls:0.37%
cases:2.51%
controls:1.17%
16
56
559
5694
11
22
564
5728
—
—
11
5
563
5741
13
21
539
5651
12
59
466
4977
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
6.1e-01
1.1e+00
2.2e+00
—
1.9e+00
1.2e+00
7.3e-01
cases:19.48%
controls:11.63%
cases:16.87%
controls:6.56%
cases:9.04%
controls:1.13%
—
—
cases:9.23%
controls:1.46%
cases:19.57%
controls:6.98%
cases:26.57%
controls:14.83%
112
669
463
5081
97
377
478
5373
52
65
523
5685
—
53
84
521
5662
108
396
444
5276
127
747
351
4289
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
6.2e-01
1.3e+00
2.1e+00
—
2.1e+00
9.4e-01
6.5e-01
cases:17.22%
controls:10.10%
cases:17.04%
controls:5.50%
cases:7.13%
controls:0.92%
—
—
cases:6.10%
controls:0.80%
cases:13.04%
controls:5.52%
cases:21.97%
controls:12.83%
99
581
476
5169
98
316
477
5434
41
53
534
5697
—
35
46
539
5700
72
313
480
5359
105
646
373
4390
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
5.9e-01
1.1e+00
2.2e+00
—
1.9e+00
1.2e+00
7.3e-01
cases:19.30%
controls:11.69%
cases:16.87%
controls:6.56%
cases:9.04%
controls:1.13%
—
—
cases:9.23%
controls:1.46%
cases:19.57%
controls:7.03%
cases:26.57%
controls:14.81%
111
672
464
5078
97
377
478
5373
52
65
523
5685
—
53
84
521
5662
108
399
444
5273
127
746
351
4290
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
5.2e-01
1.1e+00
2.9e+00
—
2.5e+00
1.1e+00
6.0e-01
cases:7.30%
controls:4.49%
cases:4.00%
controls:1.41%
cases:2.26%
controls:0.12%
—
—
cases:2.09%
controls:0.17%
cases:3.44%
controls:1.16%
cases:6.90%
controls:3.89%
42
258
533
5492
23
81
552
5669
13
7
562
5743
—
12
10
562
5736
19
66
533
5606
33
196
445
4840
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
7.3e-01
1.2e+00
2.2e+00
1.0e+50
1.6e+00
9.5e-01
9.0e-01
cases:14.26%
controls:7.39%
cases:7.48%
controls:2.33%
cases:2.78%
controls:0.33%
cases:2.61%
controls:0.00%
cases:1.39%
controls:0.28%
cases:6.88%
controls:2.79%
cases:16.95%
controls:7.68%
82
425
493
5325
43
134
532
5616
16
19
559
5731
15
0
560
5750
8
16
566
5730
38
158
514
5514
81
387
397
4649
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
7.8e-01
1.8e+00
2.9e+00
—
—
1.5e+00
1.3e+00
cases:2.43%
controls:1.13%
cases:2.43%
controls:0.40%
cases:2.26%
controls:0.12%
—
—
—
—
cases:1.99%
controls:0.46%
cases:3.97%
controls:1.09%
14
65
561
5685
14
23
561
5727
13
7
562
5743
—
—
11
26
541
5646
19
55
459
4981
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
6.0e-01
1.0e+00
2.2e+00
—
1.9e+00
1.2e+00
7.0e-01
cases:20.00%
controls:12.10%
cases:16.87%
controls:6.77%
cases:9.57%
controls:1.18%
—
—
cases:9.41%
controls:1.55%
cases:19.93%
controls:7.26%
cases:26.78%
controls:15.43%
115
696
460
5054
97
389
478
5361
55
68
520
5682
—
54
89
520
5657
110
412
442
5260
128
777
350
4259
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
5.6e-01
1.9e+00
—
—
2.4e+00
2.0e+00
1.1e+00
cases:1.57%
controls:0.90%
cases:4.35%
controls:0.66%
—
—
—
—
cases:1.39%
controls:0.12%
cases:3.62%
controls:0.49%
cases:6.69%
controls:2.24%
9
52
566
5698
25
38
550
5712
—
—
8
7
566
5739
20
28
532
5644
32
113
446
4923
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
5.6e-01
1.1e+00
2.1e+00
—
1.9e+00
1.1e+00
7.2e-01
cases:19.48%
controls:12.19%
cases:17.39%
controls:6.78%
cases:9.04%
controls:1.18%
—
—
cases:9.23%
controls:1.50%
cases:19.57%
controls:7.21%
cases:26.99%
controls:15.25%
112
701
463
5049
100
390
475
5360
52
68
523
5682
—
53
86
521
5660
108
409
444
5263
129
768
349
4268
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
6.9e-01
1.3e+00
1.9e+00
—
2.6e+00
1.5e+00
5.4e-01
cases:3.13%
controls:1.60%
cases:3.13%
controls:0.87%
cases:1.57%
controls:0.23%
—
—
cases:1.92%
controls:0.14%
cases:4.17%
controls:0.92%
cases:2.72%
controls:1.61%
18
92
557
5658
18
50
557
5700
9
13
566
5737
—
11
8
563
5738
23
52
529
5620
13
81
465
4955
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
2.0e+00
2.4e+00
—
—
—
3.0e+00
1.5e+00
cases:2.96%
controls:0.42%
cases:2.09%
controls:0.19%
—
—
—
—
—
—
cases:2.17%
controls:0.11%
cases:1.67%
controls:0.40%
17
24
558
5726
12
11
563
5739
—
—
—
12
6
540
5666
8
20
470
5016
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
1.5e+00
2.3e+00
—
—
—
1.8e+00
1.7e+00
cases:2.43%
controls:0.56%
cases:2.26%
controls:0.23%
—
—
—
—
—
—
cases:1.63%
controls:0.26%
cases:2.72%
controls:0.52%
14
32
561
5718
13
13
562
5737
—
—
—
9
15
543
5657
13
26
465
5010
Psychiatry
26 [38004469]
26 [38004469]
7.3e-01
1.2e+00
1.6e+00
—
1.5e+00
1.3e+00
1.0e+00
cases:12.17%
controls:6.24%
cases:9.39%
controls:2.99%
cases:4.87%
controls:1.04%
—
—
cases:4.70%
controls:1.08%
cases:10.33%
controls:3.10%
cases:14.02%
controls:5.64%
70
359
505
5391
54
172
521
5578
28
60
547
5690
—
27
62
547
5684
57
176
495
5496
67
284
411
4752
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
3.4e-01
7.7e-01
2.0e+00
1.0e+50
2.3e+00
1.5e+00
6.9e-01
cases:9.74%
controls:7.11%
cases:5.91%
controls:2.82%
cases:1.91%
controls:0.26%
cases:1.39%
controls:0.00%
cases:2.79%
controls:0.28%
cases:9.24%
controls:2.26%
cases:11.72%
controls:6.25%
56
409
519
5341
34
162
541
5588
11
15
564
5735
8
0
567
5750
16
16
558
5730
51
128
501
5544
56
315
422
4721
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
7.8e-01
1.4e+00
—
—
3.0e+00
1.2e+00
8.1e-01
cases:5.74%
controls:2.71%
cases:3.48%
controls:0.85%
—
—
—
—
cases:2.44%
controls:0.12%
cases:2.54%
controls:0.79%
cases:5.44%
controls:2.50%
33
156
542
5594
20
49
555
5701
—
—
14
7
560
5739
14
45
538
5627
26
126
452
4910
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.0e+00
1.9e+00
—
—
2.0e+00
1.4e+00
9.0e-01
cases:4.35%
controls:1.62%
cases:5.39%
controls:0.83%
—
—
—
—
cases:1.39%
controls:0.19%
cases:3.26%
controls:0.85%
cases:6.28%
controls:2.66%
25
93
550
5657
31
48
544
5702
—
—
8
11
566
5735
18
48
534
5624
30
134
448
4902
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
1.5e+00
2.3e+00
—
—
—
1.8e+00
1.6e+00
cases:2.43%
controls:0.56%
cases:2.26%
controls:0.23%
—
—
—
—
—
—
cases:1.63%
controls:0.28%
cases:2.72%
controls:0.56%
14
32
561
5718
13
13
562
5737
—
—
—
9
16
543
5656
13
28
465
5008
Infectious Disease
44 [38004484]
44 [38004484]
9.1e-01
1.5e+00
1.8e+00
1.0e+50
2.5e+00
1.3e+00
9.4e-01
cases:4.00%
controls:1.65%
cases:2.26%
controls:0.52%
cases:1.04%
controls:0.17%
cases:1.39%
controls:0.00%
cases:1.74%
controls:0.14%
cases:2.54%
controls:0.71%
cases:4.39%
controls:1.77%
23
95
552
5655
13
30
562
5720
6
10
569
5740
8
0
567
5750
10
8
564
5738
14
40
538
5632
21
89
457
4947
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
1.7e+00
2.9e+00
—
—
—
2.5e+00
4.9e-01
cases:2.61%
controls:0.47%
cases:2.96%
controls:0.17%
—
—
—
—
—
—
cases:1.99%
controls:0.16%
cases:1.26%
controls:0.77%
15
27
560
5723
17
10
558
5740
—
—
—
11
9
541
5663
6
39
472
4997
Cardiology
6 [38004451]
6 [38004451]
5.9e-01
1.2e+00
1.4e+00
1.0e+50
1.6e+00
1.3e+00
9.7e-01
cases:14.78%
controls:8.80%
cases:11.65%
controls:3.90%
cases:2.43%
controls:0.61%
cases:5.04%
controls:0.00%
cases:3.14%
controls:0.64%
cases:12.68%
controls:3.68%
cases:22.38%
controls:9.83%
85
506
490
5244
67
224
508
5526
14
35
561
5715
29
0
546
5750
18
37
556
5709
70
209
482
5463
107
495
371
4541
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.9e-01
1.0e+00
2.2e+00
—
1.9e+00
9.6e-01
6.2e-01
cases:27.30%
controls:20.30%
cases:26.09%
controls:11.37%
cases:16.17%
controls:2.19%
—
—
cases:12.89%
controls:2.09%
cases:25.18%
controls:11.41%
cases:36.61%
controls:23.63%
157
1167
418
4583
150
654
425
5096
93
126
482
5624
—
74
120
500
5626
139
647
413
5025
175
1190
303
3846
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
-3.1e-01
1.2e+00
2.4e+00
—
1.7e+00
1.0e+00
7.1e-01
cases:2.96%
controls:4.00%
cases:7.48%
controls:2.45%
cases:2.78%
controls:0.26%
—
—
cases:2.26%
controls:0.42%
cases:8.15%
controls:3.01%
cases:14.23%
controls:7.53%
17
230
558
5520
43
141
532
5609
16
15
559
5735
—
13
24
561
5722
45
171
507
5501
68
379
410
4657
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
1.4e+00
2.3e+00
—
—
—
1.7e+00
1.6e+00
cases:2.43%
controls:0.61%
cases:2.26%
controls:0.23%
—
—
—
—
—
—
cases:1.63%
controls:0.30%
cases:2.72%
controls:0.58%
14
35
561
5715
13
13
562
5737
—
—
—
9
17
543
5655
13
29
465
5007
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
6.9e-01
8.6e-01
2.0e+00
—
1.7e+00
9.9e-01
6.4e-01
cases:17.57%
controls:9.65%
cases:16.35%
controls:7.65%
cases:9.57%
controls:1.36%
—
—
cases:8.71%
controls:1.64%
cases:18.66%
controls:7.86%
cases:24.48%
controls:14.65%
101
555
474
5195
94
440
481
5310
55
78
520
5672
—
50
94
524
5652
103
446
449
5226
117
738
361
4298
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
1.2e+00
2.2e+00
—
—
—
1.8e+00
1.5e+00
cases:2.43%
controls:0.71%
cases:2.26%
controls:0.24%
—
—
—
—
—
—
cases:1.81%
controls:0.30%
cases:2.72%
controls:0.60%
14
41
561
5709
13
14
562
5736
—
—
—
10
17
542
5655
13
30
465
5006
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
1.3e+00
2.2e+00
—
—
—
1.8e+00
1.5e+00
cases:2.43%
controls:0.68%
cases:2.26%
controls:0.24%
—
—
—
—
—
—
cases:1.81%
controls:0.30%
cases:2.72%
controls:0.64%
14
39
561
5711
13
14
562
5736
—
—
—
10
17
542
5655
13
32
465
5004
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
3.7e-01
9.0e-01
2.1e+00
1.0e+50
2.1e+00
9.3e-01
8.1e-01
cases:9.04%
controls:6.40%
cases:6.09%
controls:2.56%
cases:2.09%
controls:0.26%
cases:0.87%
controls:0.00%
cases:2.44%
controls:0.31%
cases:6.34%
controls:2.59%
cases:16.11%
controls:7.90%
52
368
523
5382
35
147
540
5603
12
15
563
5735
5
0
570
5750
14
18
560
5728
35
147
517
5525
77
398
401
4638
Outpatient Hospital
22 [8756]
22 [8756]
3.1e-01
8.1e-01
1.8e+00
1.0e+50
2.1e+00
1.3e+00
8.2e-01
cases:31.65%
controls:25.41%
cases:12.17%
controls:5.83%
cases:4.00%
controls:0.68%
cases:3.65%
controls:0.00%
cases:4.53%
controls:0.57%
cases:14.67%
controls:4.60%
cases:26.57%
controls:13.74%
182
1461
393
4289
70
335
505
5415
23
39
552
5711
21
0
554
5750
26
33
548
5713
81
261
471
5411
127
692
351
4344
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
1.4e+00
2.2e+00
—
—
—
1.7e+00
1.4e+00
cases:2.43%
controls:0.63%
cases:2.26%
controls:0.24%
—
—
—
—
—
—
cases:1.63%
controls:0.30%
cases:2.72%
controls:0.66%
14
36
561
5714
13
14
562
5736
—
—
—
9
17
543
5655
13
33
465
5003
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
1.6e+00
2.7e+00
—
—
—
2.5e+00
5.4e-01
cases:2.43%
controls:0.49%
cases:2.26%
controls:0.16%
—
—
—
—
—
—
cases:1.81%
controls:0.16%
cases:1.26%
controls:0.73%
14
28
561
5722
13
9
562
5741
—
—
—
10
9
542
5663
6
37
472
4999
Emergency Room Visit
ER [9203]
ER [9203]
4.5e-01
1.1e+00
2.1e+00
—
1.3e+00
1.1e+00
6.8e-01
cases:45.04%
controls:34.33%
cases:25.04%
controls:10.05%
cases:9.04%
controls:1.20%
—
—
cases:5.05%
controls:1.44%
cases:23.73%
controls:9.29%
cases:41.21%
controls:26.25%
259
1974
316
3776
144
578
431
5172
52
69
523
5681
—
29
83
545
5663
131
527
421
5145
197
1322
281
3714
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
9.9e-01
9.6e-01
7.6e-01
8.8e-01
6.9e-01
9.4e-01
1.4e+00
cases:97.91%
controls:94.56%
cases:93.04%
controls:83.62%
cases:63.13%
controls:44.37%
cases:5.74%
controls:2.45%
cases:62.02%
controls:44.92%
cases:93.12%
controls:84.10%
cases:98.95%
controls:95.83%
563
5437
12
313
535
4808
40
942
363
2551
212
3199
33
141
542
5609
356
2581
218
3165
514
4770
38
902
473
4826
5
210
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
6.0e-01
1.7e+00
1.8e+00
—
2.6e+00
1.5e+00
8.2e-01
cases:4.87%
controls:2.73%
cases:5.22%
controls:0.99%
cases:1.04%
controls:0.17%
—
—
cases:1.39%
controls:0.10%
cases:3.44%
controls:0.78%
cases:5.65%
controls:2.56%
28
157
547
5593
30
57
545
5693
6
10
569
5740
—
8
6
566
5740
19
44
533
5628
27
129
451
4907
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
1.2e+00
2.2e+00
—
—
—
1.8e+00
1.4e+00
cases:2.43%
controls:0.73%
cases:2.26%
controls:0.24%
—
—
—
—
—
—
cases:1.81%
controls:0.32%
cases:2.72%
controls:0.68%
14
42
561
5708
13
14
562
5736
—
—
—
10
18
542
5654
13
34
465
5002
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
1.2e+00
2.2e+00
—
—
—
1.8e+00
1.4e+00
cases:2.43%
controls:0.73%
cases:2.26%
controls:0.24%
—
—
—
—
—
—
cases:1.81%
controls:0.32%
cases:2.72%
controls:0.68%
14
42
561
5708
13
14
562
5736
—
—
—
10
18
542
5654
13
34
465
5002
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
1.2e+00
2.2e+00
—
—
—
1.8e+00
1.4e+00
cases:2.43%
controls:0.73%
cases:2.26%
controls:0.24%
—
—
—
—
—
—
cases:1.81%
controls:0.32%
cases:2.72%
controls:0.68%
14
42
561
5708
13
14
562
5736
—
—
—
10
18
542
5654
13
34
465
5002
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
5.6e-01
8.9e-01
2.3e+00
—
1.4e+00
9.7e-01
4.4e-01
cases:15.30%
controls:9.39%
cases:12.35%
controls:5.46%
cases:5.22%
controls:0.56%
—
—
cases:3.83%
controls:0.96%
cases:14.31%
controls:5.94%
cases:22.59%
controls:15.77%
88
540
487
5210
71
314
504
5436
30
32
545
5718
—
22
55
552
5691
79
337
473
5335
108
794
370
4242
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
1.9e-01
5.3e-01
1.5e+00
3.0e+00
1.1e+00
3.9e-01
2.8e-01
cases:31.65%
controls:27.63%
cases:24.17%
controls:15.81%
cases:8.52%
controls:2.05%
cases:1.74%
controls:0.09%
cases:5.92%
controls:1.97%
cases:21.56%
controls:15.73%
cases:42.47%
controls:35.90%
182
1589
393
4161
139
909
436
4841
49
118
526
5632
10
5
565
5745
34
113
540
5633
119
892
433
4780
203
1808
275
3228
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
5.9e-01
7.1e-01
2.3e+00
—
1.8e+00
1.0e+00
4.8e-01
cases:9.04%
controls:5.22%
cases:5.04%
controls:2.54%
cases:2.09%
controls:0.21%
—
—
cases:2.26%
controls:0.37%
cases:6.70%
controls:2.49%
cases:10.67%
controls:6.89%
52
300
523
5450
29
146
546
5604
12
12
563
5738
—
13
21
561
5725
37
141
515
5531
51
347
427
4689
Gastroenterology
10 [38004455]
10 [38004455]
8.1e-01
1.0e+00
1.1e+00
—
2.0e+00
1.4e+00
1.2e+00
cases:10.61%
controls:5.03%
cases:5.57%
controls:2.07%
cases:1.57%
controls:0.52%
—
—
cases:3.83%
controls:0.52%
cases:8.51%
controls:2.26%
cases:17.15%
controls:5.62%
61
289
514
5461
32
119
543
5631
9
30
566
5720
—
22
30
552
5716
47
128
505
5544
82
283
396
4753
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
4.2e-01
7.4e-01
1.5e+00
—
2.1e+00
1.2e+00
1.0e+00
cases:12.70%
controls:8.70%
cases:7.48%
controls:3.72%
cases:2.43%
controls:0.57%
—
—
cases:3.66%
controls:0.45%
cases:9.78%
controls:3.28%
cases:19.67%
controls:8.16%
73
500
502
5250
43
214
532
5536
14
33
561
5717
—
21
26
553
5720
54
186
498
5486
94
411
384
4625
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
3.8e-01
1.1e+00
2.0e+00
1.0e+50
1.8e+00
8.4e-01
6.8e-01
cases:13.22%
controls:9.41%
cases:6.26%
controls:2.16%
cases:2.09%
controls:0.28%
cases:1.57%
controls:0.00%
cases:2.26%
controls:0.38%
cases:4.71%
controls:2.08%
cases:10.04%
controls:5.34%
76
541
499
5209
36
124
539
5626
12
16
563
5734
9
0
566
5750
13
22
561
5724
26
118
526
5554
48
269
430
4767
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
1.6e+00
2.6e+00
—
—
—
2.3e+00
8.0e-01
cases:2.43%
controls:0.52%
cases:2.26%
controls:0.17%
—
—
—
—
—
—
cases:1.81%
controls:0.19%
cases:1.88%
controls:0.85%
14
30
561
5720
13
10
562
5740
—
—
—
10
11
542
5661
9
43
469
4993
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
8.1e-01
1.2e+00
—
—
2.9e+00
1.5e+00
6.9e-01
cases:5.57%
controls:2.56%
cases:3.48%
controls:1.10%
—
—
—
—
cases:2.26%
controls:0.12%
cases:3.44%
controls:0.83%
cases:4.81%
controls:2.48%
32
147
543
5603
20
63
555
5687
—
—
13
7
561
5739
19
47
533
5625
23
125
455
4911
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
8.2e-01
1.0e+00
—
1.0e+50
2.2e+00
1.5e+00
8.8e-01
cases:9.91%
controls:4.61%
cases:3.48%
controls:1.25%
—
—
cases:5.91%
controls:0.00%
cases:1.05%
controls:0.12%
cases:3.99%
controls:0.93%
cases:6.07%
controls:2.62%
57
265
518
5485
20
72
555
5678
—
34
0
541
5750
6
7
568
5739
22
53
530
5619
29
132
449
4904
Pulmonary Disease
29 [38004472]
29 [38004472]
6.8e-01
1.1e+00
1.4e+00
1.0e+50
1.4e+00
1.0e+00
7.1e-01
cases:13.91%
controls:7.60%
cases:11.13%
controls:3.97%
cases:2.78%
controls:0.70%
cases:2.78%
controls:0.00%
cases:2.96%
controls:0.73%
cases:10.69%
controls:4.07%
cases:16.11%
controls:8.60%
80
437
495
5313
64
228
511
5522
16
40
559
5710
16
0
559
5750
17
42
557
5704
59
231
493
5441
77
433
401
4603
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
6.0e-02
2.7e-01
1.4e+00
3.8e+00
1.1e+00
2.8e-01
2.4e-01
cases:44.35%
controls:42.87%
cases:46.09%
controls:39.51%
cases:36.70%
controls:12.54%
cases:26.09%
controls:0.77%
cases:31.53%
controls:12.86%
cases:47.28%
controls:40.46%
cases:64.02%
controls:58.28%
255
2465
320
3285
265
2272
310
3478
211
721
364
5029
150
44
425
5706
181
739
393
5007
261
2295
291
3377
306
2935
172
2101
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
5.6e-01
7.0e-01
1.8e+00
—
1.7e+00
1.0e+00
4.9e-01
cases:12.00%
controls:7.22%
cases:6.43%
controls:3.29%
cases:3.13%
controls:0.52%
—
—
cases:3.31%
controls:0.63%
cases:8.70%
controls:3.23%
cases:13.60%
controls:8.76%
69
415
506
5335
37
189
538
5561
18
30
557
5720
—
19
36
555
5710
48
183
504
5489
65
441
413
4595
Oxygen saturation in Venous blood
2711-0 [3024928]
2711-0 [3024928]
1.8e+00
2.6e+00
—
—
—
—
1.9e+00
cases:1.39%
controls:0.24%
cases:1.39%
controls:0.10%
—
—
—
—
—
—
—
—
cases:4.18%
controls:0.68%
8
14
567
5736
8
6
567
5744
—
—
—
—
20
34
458
5002
Neurology
13 [38004458]
13 [38004458]
4.4e-01
9.4e-01
1.6e+00
—
1.4e+00
9.2e-01
8.2e-01
cases:13.91%
controls:9.41%
cases:9.74%
controls:4.03%
cases:3.83%
controls:0.78%
—
—
cases:4.01%
controls:0.97%
cases:10.69%
controls:4.57%
cases:18.62%
controls:9.15%
80
541
495
5209
56
232
519
5518
22
45
553
5705
—
23
56
551
5690
59
259
493
5413
89
461
389
4575
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
9.6e-01
1.3e+00
2.6e+00
1.0e+50
2.1e+00
1.2e+00
5.6e-01
cases:2.96%
controls:1.15%
cases:2.26%
controls:0.63%
cases:1.22%
controls:0.09%
cases:1.04%
controls:0.00%
cases:0.87%
controls:0.10%
cases:3.08%
controls:0.92%
cases:5.02%
controls:2.94%
17
66
558
5684
13
36
562
5714
7
5
568
5745
6
0
569
5750
5
6
569
5740
17
52
535
5620
24
148
454
4888
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
2.2e-01
1.4e+00
1.9e+00
1.0e+50
1.7e+00
1.1e+00
3.6e-01
cases:4.87%
controls:3.93%
cases:8.17%
controls:2.21%
cases:3.13%
controls:0.49%
cases:1.39%
controls:0.00%
cases:2.26%
controls:0.44%
cases:8.88%
controls:3.01%
cases:12.34%
controls:8.94%
28
226
547
5524
47
127
528
5623
18
28
557
5722
8
0
567
5750
13
25
561
5721
49
171
503
5501
59
450
419
4586
Inpatient Hospital
21 [8717]
21 [8717]
3.6e-01
8.5e-01
1.5e+00
1.0e+50
1.5e+00
1.1e+00
7.1e-01
cases:40.87%
controls:32.57%
cases:18.61%
controls:8.89%
cases:5.57%
controls:1.27%
cases:8.35%
controls:0.00%
cases:5.92%
controls:1.39%
cases:20.29%
controls:7.99%
cases:34.10%
controls:20.31%
235
1873
340
3877
107
511
468
5239
32
73
543
5677
48
0
527
5750
34
80
540
5666
112
453
440
5219
163
1023
315
4013
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
6.2e-01
1.2e+00
—
—
1.9e+00
1.2e+00
1.0e+00
cases:8.70%
controls:4.89%
cases:4.35%
controls:1.41%
—
—
—
—
cases:1.39%
controls:0.21%
cases:3.99%
controls:1.22%
cases:9.41%
controls:3.61%
50
281
525
5469
25
81
550
5669
—
—
8
12
566
5734
22
69
530
5603
45
182
433
4854
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
4.3e-01
1.1e+00
2.0e+00
1.0e+50
1.8e+00
8.9e-01
4.2e-01
cases:7.30%
controls:4.89%
cases:9.04%
controls:3.08%
cases:2.61%
controls:0.37%
cases:2.78%
controls:0.00%
cases:3.14%
controls:0.54%
cases:7.79%
controls:3.37%
cases:13.39%
controls:9.23%
42
281
533
5469
52
177
523
5573
15
21
560
5729
16
0
559
5750
18
31
556
5715
43
191
509
5481
64
465
414
4571
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
1.6e+00
2.1e+00
—
—
—
2.1e+00
1.6e+00
cases:1.22%
controls:0.24%
cases:1.39%
controls:0.17%
—
—
—
—
—
—
cases:1.09%
controls:0.14%
cases:2.09%
controls:0.42%
7
14
568
5736
8
10
567
5740
—
—
—
6
8
546
5664
10
21
468
5015
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
4.7e-01
7.8e-01
2.1e+00
—
1.5e+00
7.8e-01
3.1e-01
cases:12.87%
controls:8.42%
cases:7.83%
controls:3.76%
cases:2.61%
controls:0.33%
—
—
cases:1.74%
controls:0.38%
cases:8.33%
controls:3.98%
cases:17.36%
controls:13.30%
74
484
501
5266
45
216
530
5534
15
19
560
5731
—
10
22
564
5724
46
226
506
5446
83
670
395
4366
General Surgery
2 [38004447]
2 [38004447]
4.3e-01
7.9e-01
1.3e+00
—
1.6e+00
8.5e-01
6.0e-01
cases:22.09%
controls:15.57%
cases:10.09%
controls:4.85%
cases:2.43%
controls:0.66%
—
—
cases:3.14%
controls:0.63%
cases:9.78%
controls:4.43%
cases:19.67%
controls:11.85%
127
895
448
4855
58
279
517
5471
14
38
561
5712
—
18
36
556
5710
54
251
498
5421
94
597
384
4439
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
1.5e+00
2.3e+00
—
—
—
1.8e+00
8.1e-01
cases:3.30%
controls:0.73%
cases:1.91%
controls:0.19%
—
—
—
—
—
—
cases:1.81%
controls:0.32%
cases:2.30%
controls:1.03%
19
42
556
5708
11
11
564
5739
—
—
—
10
18
542
5654
11
52
467
4984
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
8.1e-01
1.6e+00
—
—
—
1.8e+00
1.4e+00
cases:3.83%
controls:1.74%
cases:2.09%
controls:0.43%
—
—
—
—
—
—
cases:1.63%
controls:0.28%
cases:4.18%
controls:1.03%
22
100
553
5650
12
25
563
5725
—
—
—
9
16
543
5656
20
52
458
4984
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
8.1e-01
1.6e+00
—
—
—
1.8e+00
1.4e+00
cases:3.83%
controls:1.74%
cases:2.09%
controls:0.43%
—
—
—
—
—
—
cases:1.63%
controls:0.28%
cases:4.18%
controls:1.03%
22
100
553
5650
12
25
563
5725
—
—
—
9
16
543
5656
20
52
458
4984
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
8.1e-01
1.6e+00
—
—
—
1.8e+00
1.4e+00
cases:3.83%
controls:1.74%
cases:2.09%
controls:0.43%
—
—
—
—
—
—
cases:1.63%
controls:0.28%
cases:4.18%
controls:1.03%
22
100
553
5650
12
25
563
5725
—
—
—
9
16
543
5656
20
52
458
4984
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
8.1e-01
1.6e+00
—
—
—
1.8e+00
1.4e+00
cases:3.83%
controls:1.74%
cases:2.09%
controls:0.43%
—
—
—
—
—
—
cases:1.63%
controls:0.28%
cases:4.18%
controls:1.03%
22
100
553
5650
12
25
563
5725
—
—
—
9
16
543
5656
20
52
458
4984
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
8.1e-01
1.6e+00
—
—
—
1.8e+00
1.4e+00
cases:3.83%
controls:1.74%
cases:2.09%
controls:0.43%
—
—
—
—
—
—
cases:1.63%
controls:0.28%
cases:4.18%
controls:1.03%
22
100
553
5650
12
25
563
5725
—
—
—
9
16
543
5656
20
52
458
4984
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
5.9e-01
1.0e+00
1.3e+00
1.0e+50
2.4e+00
1.3e+00
8.7e-01
cases:4.70%
controls:2.66%
cases:3.65%
controls:1.34%
cases:1.04%
controls:0.30%
cases:1.91%
controls:0.00%
cases:2.09%
controls:0.19%
cases:4.71%
controls:1.36%
cases:8.58%
controls:3.77%
27
153
548
5597
21
77
554
5673
6
17
569
5733
11
0
564
5750
12
11
562
5735
26
77
526
5595
41
190
437
4846
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
5.3e-01
9.3e-01
1.9e+00
—
1.9e+00
6.3e-01
8.9e-01
cases:7.30%
controls:4.45%
cases:6.26%
controls:2.57%
cases:2.09%
controls:0.33%
—
—
cases:1.57%
controls:0.24%
cases:5.43%
controls:2.98%
cases:16.53%
controls:7.51%
42
256
533
5494
36
148
539
5602
12
19
563
5731
—
9
14
565
5732
30
169
522
5503
79
378
399
4658
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
9.1e-01
1.3e+00
2.8e+00
1.0e+50
2.1e+00
1.4e+00
6.8e-01
cases:2.96%
controls:1.22%
cases:2.26%
controls:0.63%
cases:1.39%
controls:0.09%
cases:1.04%
controls:0.00%
cases:0.87%
controls:0.10%
cases:3.26%
controls:0.85%
cases:5.02%
controls:2.60%
17
70
558
5680
13
36
562
5714
8
5
567
5745
6
0
569
5750
5
6
569
5740
18
48
534
5624
24
131
454
4905
Emergency Medicine
93 [38004510]
93 [38004510]
-6.5e-02
8.4e-01
2.1e+00
—
1.7e+00
6.9e-01
3.2e-01
cases:13.22%
controls:13.98%
cases:16.35%
controls:7.77%
cases:8.52%
controls:1.08%
—
—
cases:6.27%
controls:1.17%
cases:15.58%
controls:8.44%
cases:26.57%
controls:20.85%
76
804
499
4946
94
447
481
5303
49
62
526
5688
—
36
67
538
5679
86
479
466
5193
127
1050
351
3986
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
5.1e-01
9.4e-01
—
1.0e+50
3.3e+00
1.2e+00
6.0e-01
cases:7.30%
controls:4.52%
cases:3.30%
controls:1.32%
—
—
cases:1.39%
controls:0.00%
cases:2.26%
controls:0.09%
cases:3.26%
controls:1.04%
cases:6.49%
controls:3.65%
42
260
533
5490
19
76
556
5674
—
8
0
567
5750
13
5
561
5741
18
59
534
5613
31
184
447
4852
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
7.2e-01
1.5e+00
—
—
1.8e+00
1.3e+00
7.4e-01
cases:3.13%
controls:1.55%
cases:5.04%
controls:1.13%
—
—
—
—
cases:1.22%
controls:0.21%
cases:3.80%
controls:1.04%
cases:6.90%
controls:3.42%
18
89
557
5661
29
65
546
5685
—
—
7
12
567
5734
21
59
531
5613
33
172
445
4864
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
6.8e-01
1.1e+00
1.5e+00
—
1.3e+00
1.2e+00
8.4e-01
cases:7.48%
controls:3.95%
cases:4.35%
controls:1.57%
cases:1.91%
controls:0.42%
—
—
cases:1.57%
controls:0.45%
cases:5.80%
controls:1.75%
cases:8.16%
controls:3.69%
43
227
532
5523
25
90
550
5660
11
24
564
5726
—
9
26
565
5720
32
99
520
5573
39
186
439
4850
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
6.6e-01
8.0e-01
1.7e+00
—
1.7e+00
5.4e-01
4.9e-01
cases:13.91%
controls:7.72%
cases:9.39%
controls:4.47%
cases:2.09%
controls:0.40%
—
—
cases:2.79%
controls:0.50%
cases:8.33%
controls:5.04%
cases:20.92%
controls:13.98%
80
444
495
5306
54
257
521
5493
12
23
563
5727
—
16
29
558
5717
46
286
506
5386
100
704
378
4332
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
9.8e-01
1.7e+00
—
—
—
1.7e+00
9.8e-01
cases:3.30%
controls:1.27%
cases:2.61%
controls:0.49%
—
—
—
—
—
—
cases:3.26%
controls:0.63%
cases:3.97%
controls:1.53%
19
73
556
5677
15
28
560
5722
—
—
—
18
36
534
5636
19
77
459
4959
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
3.9e-01
1.3e+00
1.9e+00
—
1.6e+00
1.3e+00
8.1e-01
cases:2.26%
controls:1.55%
cases:2.78%
controls:0.75%
cases:1.22%
controls:0.19%
—
—
cases:1.05%
controls:0.21%
cases:3.08%
controls:0.86%
cases:4.81%
controls:2.20%
13
89
562
5661
16
43
559
5707
7
11
568
5739
—
6
12
568
5734
17
49
535
5623
23
111
455
4925
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.1e-01
5.7e-01
2.0e+00
—
1.4e+00
8.1e-01
4.9e-01
cases:16.17%
controls:12.43%
cases:10.96%
controls:6.50%
cases:4.87%
controls:0.70%
—
—
cases:3.14%
controls:0.77%
cases:12.14%
controls:5.78%
cases:22.38%
controls:15.01%
93
715
482
5035
63
374
512
5376
28
40
547
5710
—
18
44
556
5702
67
328
485
5344
107
756
371
4280
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
8.1e-01
1.5e+00
—
—
—
2.4e+00
1.3e+00
cases:2.09%
controls:0.94%
cases:2.61%
controls:0.59%
—
—
—
—
—
—
cases:3.26%
controls:0.30%
cases:4.81%
controls:1.37%
12
54
563
5696
15
34
560
5716
—
—
—
18
17
534
5655
23
69
455
4967
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
5.0e-01
9.9e-01
—
—
2.8e+00
1.6e+00
8.2e-01
cases:4.52%
controls:2.80%
cases:2.09%
controls:0.78%
—
—
—
—
cases:1.39%
controls:0.09%
cases:3.26%
controls:0.69%
cases:5.23%
controls:2.38%
26
161
549
5589
12
45
563
5705
—
—
8
5
566
5741
18
39
534
5633
25
120
453
4916
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.4e-01
5.9e-01
1.4e+00
1.0e+50
1.9e+00
1.2e+00
4.2e-01
cases:11.48%
controls:10.12%
cases:7.48%
controls:4.28%
cases:1.91%
controls:0.47%
cases:1.57%
controls:0.00%
cases:2.79%
controls:0.44%
cases:11.23%
controls:3.54%
cases:14.02%
controls:9.71%
66
582
509
5168
43
246
532
5504
11
27
564
5723
9
0
566
5750
16
25
558
5721
62
201
490
5471
67
489
411
4547
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.9e-01
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:4.00%
controls:1.86%
cases:2.26%
controls:0.63%
—
—
—
—
—
—
cases:1.63%
controls:0.35%
cases:4.81%
controls:1.13%
23
107
552
5643
13
36
562
5714
—
—
—
9
20
543
5652
23
57
455
4979
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.9e-01
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:4.00%
controls:1.86%
cases:2.26%
controls:0.63%
—
—
—
—
—
—
cases:1.63%
controls:0.35%
cases:4.81%
controls:1.13%
23
107
552
5643
13
36
562
5714
—
—
—
9
20
543
5652
23
57
455
4979
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.9e-01
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:4.00%
controls:1.86%
cases:2.26%
controls:0.63%
—
—
—
—
—
—
cases:1.63%
controls:0.35%
cases:4.81%
controls:1.13%
23
107
552
5643
13
36
562
5714
—
—
—
9
20
543
5652
23
57
455
4979
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
-5.0e-02
9.4e-01
1.9e+00
—
1.4e+00
8.4e-01
3.9e-01
cases:7.83%
controls:8.19%
cases:8.70%
controls:3.58%
cases:3.30%
controls:0.49%
—
—
cases:2.44%
controls:0.63%
cases:9.78%
controls:4.48%
cases:17.78%
controls:12.75%
45
471
530
5279
50
206
525
5544
19
28
556
5722
—
14
36
560
5710
54
254
498
5418
85
642
393
4394
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
5.6e-01
9.5e-01
—
—
2.2e+00
1.1e+00
8.1e-01
cases:5.91%
controls:3.48%
cases:3.30%
controls:1.30%
—
—
—
—
cases:1.39%
controls:0.16%
cases:3.99%
controls:1.34%
cases:7.95%
controls:3.71%
34
200
541
5550
19
75
556
5675
—
—
8
9
566
5737
22
76
530
5596
38
187
440
4849
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
1.9e-01
7.4e-01
2.1e+00
—
1.4e+00
4.9e-01
4.0e-01
cases:22.61%
controls:19.50%
cases:17.91%
controls:9.39%
cases:7.65%
controls:1.03%
—
—
cases:5.05%
controls:1.36%
cases:13.95%
controls:9.03%
cases:29.71%
controls:22.16%
130
1121
445
4629
103
540
472
5210
44
59
531
5691
—
29
78
545
5668
77
512
475
5160
142
1116
336
3920
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
3.7e-01
5.8e-01
2.0e+00
—
1.5e+00
6.1e-01
1.4e-01
cases:22.09%
controls:16.31%
cases:12.87%
controls:7.67%
cases:5.74%
controls:0.85%
—
—
cases:4.01%
controls:0.89%
cases:13.04%
controls:7.56%
cases:21.97%
controls:19.62%
127
938
448
4812
74
441
501
5309
33
49
542
5701
—
23
51
551
5695
72
429
480
5243
105
988
373
4048
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
7.0e-02
2.1e-01
6.6e-01
3.7e+00
6.9e-01
2.8e-01
1.5e-01
cases:62.43%
controls:60.78%
cases:60.17%
controls:54.94%
cases:38.26%
controls:24.28%
cases:38.26%
controls:1.53%
cases:39.20%
controls:24.35%
cases:65.76%
controls:59.17%
cases:79.71%
controls:77.10%
359
3495
216
2255
346
3159
229
2591
220
1396
355
4354
220
88
355
5662
225
1399
349
4347
363
3356
189
2316
381
3883
97
1153
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
1.0e+00
1.2e+00
1.7e+00
—
1.9e+00
8.6e-01
3.6e-01
cases:6.09%
controls:2.26%
cases:5.57%
controls:1.72%
cases:0.87%
controls:0.16%
—
—
cases:1.57%
controls:0.24%
cases:5.98%
controls:2.61%
cases:11.51%
controls:8.34%
35
130
540
5620
32
99
543
5651
5
9
570
5741
—
9
14
565
5732
33
148
519
5524
55
420
423
4616
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
1.3e+00
1.9e+00
—
1.0e+50
—
1.8e+00
7.3e-01
cases:5.91%
controls:1.76%
cases:3.13%
controls:0.50%
—
—
cases:1.04%
controls:0.00%
—
—
cases:1.81%
controls:0.30%
cases:1.67%
controls:0.81%
34
101
541
5649
18
29
557
5721
—
6
0
569
5750
—
10
17
542
5655
8
41
470
4995
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
1.1e+00
2.5e+00
—
—
—
2.4e+00
1.0e+00
cases:1.91%
controls:0.64%
cases:2.43%
controls:0.21%
—
—
—
—
—
—
cases:1.99%
controls:0.18%
cases:1.67%
controls:0.62%
11
37
564
5713
14
12
561
5738
—
—
—
11
10
541
5662
8
31
470
5005
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
5.5e-01
8.4e-01
1.6e+00
—
2.9e+00
1.2e+00
5.9e-01
cases:6.43%
controls:3.81%
cases:4.00%
controls:1.77%
cases:0.87%
controls:0.17%
—
—
cases:2.44%
controls:0.14%
cases:4.17%
controls:1.32%
cases:7.11%
controls:4.09%
37
219
538
5531
23
102
552
5648
5
10
570
5740
—
14
8
560
5738
23
75
529
5597
34
206
444
4830
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
5.8e-01
9.5e-01
1.3e+00
—
8.5e-01
9.4e-01
1.1e+00
cases:8.35%
controls:4.87%
cases:6.43%
controls:2.59%
cases:2.26%
controls:0.63%
—
—
cases:1.74%
controls:0.75%
cases:6.52%
controls:2.64%
cases:13.81%
controls:5.14%
48
280
527
5470
37
149
538
5601
13
36
562
5714
—
10
43
564
5703
36
150
516
5522
66
259
412
4777
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
33944-0 [3047169]
1.0e+00
1.9e+00
2.9e+00
—
—
1.6e+00
1.1e+00
cases:1.39%
controls:0.50%
cases:1.57%
controls:0.23%
cases:1.57%
controls:0.09%
—
—
—
—
cases:1.45%
controls:0.30%
cases:2.09%
controls:0.73%
8
29
567
5721
9
13
566
5737
9
5
566
5745
—
—
8
17
544
5655
10
37
468
4999
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
36916-5 [3034860]
1.0e+00
1.9e+00
2.9e+00
—
—
1.6e+00
1.1e+00
cases:1.39%
controls:0.50%
cases:1.57%
controls:0.23%
cases:1.57%
controls:0.09%
—
—
—
—
cases:1.45%
controls:0.30%
cases:2.09%
controls:0.73%
8
29
567
5721
9
13
566
5737
9
5
566
5745
—
—
8
17
544
5655
10
37
468
4999
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
1.2e+00
2.0e+00
—
—
—
1.7e+00
5.0e-01
cases:2.43%
controls:0.77%
cases:2.09%
controls:0.30%
—
—
—
—
—
—
cases:1.81%
controls:0.33%
cases:1.46%
controls:0.89%
14
44
561
5706
12
17
563
5733
—
—
—
10
19
542
5653
7
45
471
4991
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
9.0e-01
1.1e+00
—
—
1.5e+00
1.8e+00
9.8e-01
cases:10.61%
controls:4.61%
cases:5.39%
controls:1.77%
—
—
—
—
cases:1.39%
controls:0.31%
cases:7.07%
controls:1.22%
cases:10.88%
controls:4.39%
61
265
514
5485
31
102
544
5648
—
—
8
18
566
5728
39
69
513
5603
52
221
426
4815
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
3.7e-01
7.3e-01
1.9e+00
—
2.3e+00
7.6e-01
6.2e-01
cases:6.96%
controls:4.92%
cases:4.35%
controls:2.14%
cases:1.39%
controls:0.21%
—
—
cases:1.74%
controls:0.17%
cases:3.80%
controls:1.82%
cases:9.21%
controls:5.18%
40
283
535
5467
25
123
550
5627
8
12
567
5738
—
10
10
564
5736
21
103
531
5569
44
261
434
4775
Vascular Surgery
77 [38004496]
77 [38004496]
8.6e-01
1.5e+00
—
—
—
1.7e+00
8.1e-01
cases:5.04%
controls:2.19%
cases:3.30%
controls:0.78%
—
—
—
—
—
—
cases:3.26%
controls:0.62%
cases:6.07%
controls:2.80%
29
126
546
5624
19
45
556
5705
—
—
—
18
35
534
5637
29
141
449
4895
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
2.8e-01
7.0e-01
1.7e+00
—
1.2e+00
8.1e-01
4.0e-01
cases:20.70%
controls:16.43%
cases:15.13%
controls:8.14%
cases:5.57%
controls:1.10%
—
—
cases:4.53%
controls:1.36%
cases:16.30%
controls:7.99%
cases:25.73%
controls:18.80%
119
945
456
4805
87
468
488
5282
32
63
543
5687
—
26
78
548
5668
90
453
462
5219
123
947
355
4089
warfarin; oral, parenteral
B01AA03 [21600965]
B01AA03 [21600965]
7.7e-01
1.0e+00
6.6e-01
—
1.3e+00
8.8e-01
8.5e-01
cases:9.22%
controls:4.50%
cases:8.17%
controls:3.10%
cases:1.57%
controls:0.82%
—
—
cases:2.61%
controls:0.75%
cases:6.88%
controls:2.98%
cases:7.74%
controls:3.47%
53
259
522
5491
47
178
528
5572
9
47
566
5703
—
15
43
559
5703
38
169
514
5503
37
175
441
4861
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
-1.3e-02
7.6e-01
1.7e+00
—
1.2e+00
7.2e-01
3.8e-01
cases:10.09%
controls:10.21%
cases:10.43%
controls:5.15%
cases:4.00%
controls:0.77%
—
—
cases:2.79%
controls:0.84%
cases:11.59%
controls:5.98%
cases:23.22%
controls:17.08%
58
587
517
5163
60
296
515
5454
23
44
552
5706
—
16
48
558
5698
64
339
488
5333
111
860
367
4176
Medical Oncology
90 [38004507]
90 [38004507]
5.3e-01
7.5e-01
1.2e+00
—
1.4e+00
1.3e+00
5.4e-01
cases:5.74%
controls:3.44%
cases:5.39%
controls:2.61%
cases:3.65%
controls:1.08%
—
—
cases:3.83%
controls:0.97%
cases:8.51%
controls:2.47%
cases:6.69%
controls:4.01%
33
198
542
5552
31
150
544
5600
21
62
554
5688
—
22
56
552
5690
47
140
505
5532
32
202
446
4834
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
7.4e-01
9.8e-01
—
—
2.2e+00
1.5e+00
5.7e-01
cases:4.00%
controls:1.95%
cases:3.83%
controls:1.48%
—
—
—
—
cases:1.05%
controls:0.12%
cases:5.07%
controls:1.15%
cases:6.28%
controls:3.63%
23
112
552
5638
22
85
553
5665
—
—
6
7
568
5739
28
65
524
5607
30
183
448
4853
Kolposcopy
ULA02 [2001306679]
ULA02 [2001306679]
1.3e+00
—
—
1.0e+50
—
2.3e+00
2.3e+00
cases:1.22%
controls:0.33%
—
—
—
—
cases:2.96%
controls:0.00%
—
—
cases:1.27%
controls:0.12%
cases:2.93%
controls:0.30%
7
19
568
5731
—
—
17
0
558
5750
—
7
7
545
5665
14
15
464
5021
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
9.2e-01
1.9e+00
—
1.0e+50
—
1.8e+00
9.6e-01
cases:2.78%
controls:1.13%
cases:1.74%
controls:0.26%
—
—
cases:1.04%
controls:0.00%
—
—
cases:1.81%
controls:0.32%
cases:3.77%
controls:1.47%
16
65
559
5685
10
15
565
5735
—
6
0
569
5750
—
10
18
542
5654
18
74
460
4962
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.5e-01
6.0e-01
1.3e+00
—
1.1e+00
7.5e-01
3.7e-01
cases:39.13%
controls:29.03%
cases:14.61%
controls:8.56%
cases:3.13%
controls:0.87%
—
—
cases:2.96%
controls:0.96%
cases:16.30%
controls:8.41%
cases:34.31%
controls:26.53%
225
1669
350
4081
84
492
491
5258
18
50
557
5700
—
17
55
557
5691
90
477
462
5195
164
1336
314
3700
General Practice
1 [38004446]
1 [38004446]
4.6e-01
9.7e-01
1.7e+00
—
9.1e-01
9.4e-01
5.0e-01
cases:18.61%
controls:12.63%
cases:10.26%
controls:4.17%
cases:3.48%
controls:0.64%
—
—
cases:2.09%
controls:0.85%
cases:10.51%
controls:4.37%
cases:20.71%
controls:13.62%
107
726
468
5024
59
240
516
5510
20
37
555
5713
—
12
49
562
5697
58
248
494
5424
99
686
379
4350
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
5.0e-01
8.0e-01
8.6e-01
—
1.8e+00
7.7e-01
6.4e-01
cases:15.83%
controls:10.24%
cases:8.87%
controls:4.19%
cases:1.91%
controls:0.82%
—
—
cases:3.48%
controls:0.59%
cases:8.70%
controls:4.23%
cases:17.78%
controls:10.27%
91
589
484
5161
51
241
524
5509
11
47
564
5703
—
20
34
554
5712
48
240
504
5432
85
517
393
4519
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
5.0e-01
8.0e-01
8.6e-01
—
1.8e+00
7.6e-01
6.4e-01
cases:15.83%
controls:10.28%
cases:8.87%
controls:4.21%
cases:1.91%
controls:0.82%
—
—
cases:3.48%
controls:0.59%
cases:8.70%
controls:4.25%
cases:17.78%
controls:10.27%
91
591
484
5159
51
242
524
5508
11
47
564
5703
—
20
34
554
5712
48
241
504
5431
85
517
393
4519
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
5.8e-01
7.6e-01
1.8e+00
—
2.0e+00
1.1e+00
7.5e-01
cases:9.39%
controls:5.48%
cases:3.65%
controls:1.74%
cases:0.87%
controls:0.14%
—
—
cases:1.39%
controls:0.19%
cases:3.80%
controls:1.30%
cases:9.41%
controls:4.67%
54
315
521
5435
21
100
554
5650
5
8
570
5742
—
8
11
566
5735
21
74
531
5598
45
235
433
4801
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
-1.8e-02
7.5e-01
1.7e+00
—
1.2e+00
7.2e-01
3.8e-01
cases:9.57%
controls:9.72%
cases:9.91%
controls:4.96%
cases:3.83%
controls:0.71%
—
—
cases:2.79%
controls:0.84%
cases:11.41%
controls:5.89%
cases:23.01%
controls:16.96%
55
559
520
5191
57
285
518
5465
22
41
553
5709
—
16
48
558
5698
63
334
489
5338
110
854
368
4182
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
5.9e-01
4.9e-01
2.0e+00
—
1.8e+00
6.1e-01
4.6e-01
cases:7.13%
controls:4.09%
cases:3.30%
controls:2.05%
cases:2.09%
controls:0.28%
—
—
cases:1.92%
controls:0.33%
cases:4.71%
controls:2.63%
cases:12.76%
controls:8.44%
41
235
534
5515
19
118
556
5632
12
16
563
5734
—
11
19
563
5727
26
149
526
5523
61
425
417
4611
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
-6.3e-02
7.5e-01
1.7e+00
—
1.2e+00
7.2e-01
3.5e-01
cases:9.22%
controls:9.76%
cases:10.09%
controls:5.03%
cases:3.83%
controls:0.73%
—
—
cases:2.79%
controls:0.84%
cases:11.59%
controls:5.98%
cases:22.80%
controls:17.24%
53
561
522
5189
58
289
517
5461
22
42
553
5708
—
16
48
558
5698
64
339
488
5333
109
868
369
4168
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
1.4e-01
7.3e-01
1.8e+00
—
1.8e+00
8.0e-01
2.0e-01
cases:4.87%
controls:4.24%
cases:4.17%
controls:2.05%
cases:1.39%
controls:0.24%
—
—
cases:2.44%
controls:0.40%
cases:5.07%
controls:2.34%
cases:7.32%
controls:6.10%
28
244
547
5506
24
118
551
5632
8
14
567
5736
—
14
23
560
5723
28
133
524
5539
35
307
443
4729
Inpatient Visit
IP [9201]
IP [9201]
3.2e-01
6.5e-01
1.5e+00
—
2.0e+00
8.7e-01
4.0e-01
cases:7.13%
controls:5.30%
cases:5.57%
controls:2.97%
cases:1.74%
controls:0.38%
—
—
cases:1.74%
controls:0.24%
cases:6.52%
controls:2.84%
cases:10.25%
controls:7.11%
41
305
534
5445
32
171
543
5579
10
22
565
5728
—
10
14
564
5732
36
161
516
5511
49
358
429
4678
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
9.4e-01
1.7e+00
—
1.0e+50
—
1.6e+00
4.5e-01
cases:5.04%
controls:2.03%
cases:4.35%
controls:0.80%
—
—
cases:0.87%
controls:0.00%
—
—
cases:3.80%
controls:0.78%
cases:3.97%
controls:2.56%
29
117
546
5633
25
46
550
5704
—
5
0
570
5750
—
21
44
531
5628
19
129
459
4907
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.7e-01
5.4e-01
1.3e+00
1.0e+50
1.2e+00
7.5e-01
4.6e-01
cases:20.00%
controls:17.44%
cases:13.74%
controls:8.49%
cases:5.04%
controls:1.37%
cases:1.91%
controls:0.00%
cases:3.83%
controls:1.18%
cases:16.12%
controls:8.36%
cases:28.24%
controls:19.88%
115
1003
460
4747
79
488
496
5262
29
79
546
5671
11
0
564
5750
22
68
552
5678
89
474
463
5198
135
1001
343
4035
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
6.9e-01
9.1e-01
5.8e-01
—
1.2e+00
8.0e-01
6.8e-01
cases:27.30%
controls:15.88%
cases:19.13%
controls:8.71%
cases:3.13%
controls:1.77%
—
—
cases:6.45%
controls:2.04%
cases:18.66%
controls:9.33%
cases:30.33%
controls:18.01%
157
913
418
4837
110
501
465
5249
18
102
557
5648
—
37
117
537
5629
103
529
449
5143
145
907
333
4129
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
2589-0 [3012110]
1.2e+00
1.6e+00
—
—
—
2.3e+00
1.9e+00
cases:1.74%
controls:0.54%
cases:0.87%
controls:0.17%
—
—
—
—
—
—
cases:1.45%
controls:0.14%
cases:2.72%
controls:0.42%
10
31
565
5719
5
10
570
5740
—
—
—
8
8
544
5664
13
21
465
5015
Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49891-5 [3029511]
49891-5 [3029511]
9.2e-01
1.7e+00
—
1.0e+50
—
2.5e+00
1.8e+00
cases:1.04%
controls:0.42%
cases:1.22%
controls:0.23%
—
—
cases:2.26%
controls:0.00%
—
—
cases:1.45%
controls:0.12%
cases:2.72%
controls:0.48%
6
24
569
5726
7
13
568
5737
—
13
0
562
5750
—
8
7
544
5665
13
24
465
5012
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
1.0e+00
1.1e+00
1.4e+00
—
1.3e+00
8.4e-01
5.0e-01
cases:15.13%
controls:6.16%
cases:6.26%
controls:2.28%
cases:1.57%
controls:0.38%
—
—
cases:1.92%
controls:0.52%
cases:5.07%
controls:2.26%
cases:11.09%
controls:7.05%
87
354
488
5396
36
131
539
5619
9
22
566
5728
—
11
30
563
5716
28
128
524
5544
53
355
425
4681
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
51628-6 [3042111]
1.7e+00
—
—
1.0e+50
—
—
2.5e+00
cases:1.57%
controls:0.30%
—
—
—
—
cases:1.39%
controls:0.00%
—
—
—
—
cases:1.67%
controls:0.14%
9
17
566
5733
—
—
8
0
567
5750
—
—
8
7
470
5029
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
—
2.1e+00
—
—
—
2.1e+00
5.9e-01
—
—
cases:2.78%
controls:0.37%
—
—
—
—
—
—
cases:2.17%
controls:0.26%
cases:2.51%
controls:1.41%
—
16
21
559
5729
—
—
—
12
15
540
5657
12
71
466
4965
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
20483-4 [3034770]
1.7e+00
1.7e+00
—
—
—
2.5e+00
—
cases:2.09%
controls:0.40%
cases:0.87%
controls:0.16%
—
—
—
—
—
—
cases:1.63%
controls:0.14%
—
—
12
23
563
5727
5
9
570
5741
—
—
—
9
8
543
5664
—
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
1.2e+00
1.0e+00
—
—
—
1.6e+00
1.3e+00
cases:4.87%
controls:1.50%
cases:1.22%
controls:0.45%
—
—
—
—
—
—
cases:2.17%
controls:0.46%
cases:5.23%
controls:1.43%
28
86
547
5664
7
26
568
5724
—
—
—
12
26
540
5646
25
72
453
4964
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
14928-6 [3026989]
3.9e-01
7.0e-01
2.7e+00
—
—
1.4e+00
6.3e-01
cases:2.09%
controls:1.43%
cases:1.39%
controls:0.70%
cases:1.74%
controls:0.12%
—
—
—
—
cases:2.17%
controls:0.55%
cases:2.93%
controls:1.59%
12
82
563
5668
8
40
567
5710
10
7
565
5743
—
—
12
31
540
5641
14
80
464
4956
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
31204-1 [3013527]
1.7e+00
2.0e+00
—
—
—
2.0e+00
6.2e-01
cases:1.04%
controls:0.19%
cases:1.57%
controls:0.21%
—
—
—
—
—
—
cases:1.81%
controls:0.25%
cases:1.46%
controls:0.79%
6
11
569
5739
9
12
566
5738
—
—
—
10
14
542
5658
7
40
471
4996
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
6.9e-01
1.1e+00
—
—
—
1.5e+00
7.4e-01
cases:7.13%
controls:3.70%
cases:2.43%
controls:0.85%
—
—
—
—
—
—
cases:2.72%
controls:0.63%
cases:5.86%
controls:2.88%
41
213
534
5537
14
49
561
5701
—
—
—
15
36
537
5636
28
145
450
4891
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
1.5e+00
2.0e+00
—
—
—
2.5e+00
—
cases:2.09%
controls:0.47%
cases:0.87%
controls:0.12%
—
—
—
—
—
—
cases:1.81%
controls:0.16%
—
—
12
27
563
5723
5
7
570
5743
—
—
—
10
9
542
5663
—
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
5.6e-01
8.0e-01
1.7e+00
1.0e+50
6.7e-01
9.3e-01
4.2e-01
cases:8.17%
controls:4.85%
cases:5.04%
controls:2.33%
cases:1.91%
controls:0.37%
cases:1.39%
controls:0.00%
cases:1.05%
controls:0.54%
cases:4.71%
controls:1.92%
cases:6.49%
controls:4.35%
47
279
528
5471
29
134
546
5616
11
21
564
5729
8
0
567
5750
6
31
568
5715
26
109
526
5563
31
219
447
4817
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
8.1e-01
1.1e+00
1.1e+00
—
1.3e+00
1.2e+00
8.7e-01
cases:14.96%
controls:7.23%
cases:6.09%
controls:2.14%
cases:1.57%
controls:0.52%
—
—
cases:1.57%
controls:0.42%
cases:7.07%
controls:2.29%
cases:13.39%
controls:6.06%
86
416
489
5334
35
123
540
5627
9
30
566
5720
—
9
24
565
5722
39
130
513
5542
64
305
414
4731
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
1.7e+00
1.9e+00
—
—
—
2.1e+00
1.8e+00
cases:1.22%
controls:0.23%
cases:1.04%
controls:0.16%
—
—
—
—
—
—
cases:1.27%
controls:0.16%
cases:1.88%
controls:0.32%
7
13
568
5737
6
9
569
5741
—
—
—
7
9
545
5663
9
16
469
5020
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
3.9e-01
1.2e+00
1.8e+00
—
—
8.1e-01
3.8e-01
cases:7.30%
controls:5.08%
cases:5.74%
controls:1.77%
cases:1.74%
controls:0.28%
—
—
—
—
cases:4.71%
controls:2.15%
cases:9.83%
controls:6.91%
42
292
533
5458
33
102
542
5648
10
16
565
5734
—
—
26
122
526
5550
47
348
431
4688
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
8.4e-01
1.4e+00
—
—
—
1.6e+00
7.9e-01
cases:4.17%
controls:1.84%
cases:2.43%
controls:0.63%
—
—
—
—
—
—
cases:2.90%
controls:0.58%
cases:4.60%
controls:2.14%
24
106
551
5644
14
36
561
5714
—
—
—
16
33
536
5639
22
108
456
4928
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
1.6e+00
—
—
—
—
—
2.2e+00
cases:1.91%
controls:0.38%
—
—
—
—
—
—
—
—
—
—
cases:1.88%
controls:0.22%
11
22
564
5728
—
—
—
—
—
9
11
469
5025
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
22748-8 [3001308]
1.7e-01
1.5e-01
9.7e-01
2.8e+00
3.7e-01
1.3e-01
5.5e-02
cases:33.39%
controls:29.77%
cases:21.39%
controls:18.90%
cases:5.04%
controls:1.97%
cases:1.39%
controls:0.09%
cases:3.31%
controls:2.31%
cases:20.83%
controls:18.76%
cases:42.89%
controls:41.54%
192
1712
383
4038
123
1087
452
4663
29
113
546
5637
8
5
567
5745
19
133
555
5613
115
1064
437
4608
205
2092
273
2944
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
6.4e-01
1.6e+00
2.2e+00
1.0e+50
—
9.4e-01
4.8e-01
cases:5.39%
controls:2.92%
cases:4.52%
controls:0.97%
cases:1.22%
controls:0.14%
cases:0.87%
controls:0.00%
—
—
cases:2.36%
controls:0.93%
cases:4.39%
controls:2.76%
31
168
544
5582
26
56
549
5694
7
8
568
5742
5
0
570
5750
—
13
53
539
5619
21
139
457
4897
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.3e-01
-6.0e-02
9.4e-01
2.8e+00
3.7e-01
1.5e-02
1.1e-01
cases:37.57%
controls:34.54%
cases:20.70%
controls:21.70%
cases:9.04%
controls:3.74%
cases:3.48%
controls:0.23%
cases:5.40%
controls:3.78%
cases:19.93%
controls:19.69%
cases:42.26%
controls:39.59%
216
1986
359
3764
119
1248
456
4502
52
215
523
5535
20
13
555
5737
31
217
543
5529
110
1117
442
4555
202
1994
276
3042
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
9.9e-01
1.2e+00
2.6e+00
—
—
7.5e-01
7.6e-01
cases:3.48%
controls:1.32%
cases:2.09%
controls:0.66%
cases:1.22%
controls:0.09%
—
—
—
—
cases:1.45%
controls:0.69%
cases:4.81%
controls:2.30%
20
76
555
5674
12
38
563
5712
7
5
568
5745
—
—
8
39
544
5633
23
116
455
4920
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
2.5e-01
4.2e-01
1.1e+00
—
1.3e+00
7.5e-01
4.7e-01
cases:18.43%
controls:14.94%
cases:10.09%
controls:6.87%
cases:2.96%
controls:1.01%
—
—
cases:4.18%
controls:1.15%
cases:14.49%
controls:7.42%
cases:27.82%
controls:19.42%
106
859
469
4891
58
395
517
5355
17
58
558
5692
—
24
66
550
5680
80
421
472
5251
133
978
345
4058
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
FM1BE [2001303285]
1.4e+00
—
—
—
—
2.2e+00
—
cases:2.09%
controls:0.50%
—
—
—
—
—
—
—
—
cases:1.09%
controls:0.12%
—
—
12
29
563
5721
—
—
—
—
6
7
546
5665
—
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
5.9e-01
5.7e-01
4.5e-01
—
8.3e-01
8.3e-01
8.0e-01
cases:14.26%
controls:8.42%
cases:11.30%
controls:6.70%
cases:3.13%
controls:2.02%
—
—
cases:4.01%
controls:1.79%
cases:14.13%
controls:6.72%
cases:19.25%
controls:9.69%
82
484
493
5266
65
385
510
5365
18
116
557
5634
—
23
103
551
5643
78
381
474
5291
92
488
386
4548
magnesium hydroxide; oral
G04BX01 [21602658]
G04BX01 [21602658]
1.2e+00
—
—
—
—
1.8e+00
1.8e+00
cases:1.22%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.21%
cases:2.51%
controls:0.42%
7
22
568
5728
—
—
—
—
7
12
545
5660
12
21
466
5015
magnesium hydroxide; oral
A02AA04 [21600052]
A02AA04 [21600052]
1.2e+00
—
—
—
—
1.8e+00
1.8e+00
cases:1.22%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.21%
cases:2.51%
controls:0.42%
7
22
568
5728
—
—
—
—
7
12
545
5660
12
21
466
5015
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
9.7e-01
1.2e+00
—
—
—
1.4e+00
5.5e-01
cases:4.17%
controls:1.62%
cases:2.78%
controls:0.82%
—
—
—
—
—
—
cases:2.17%
controls:0.55%
cases:2.93%
controls:1.71%
24
93
551
5657
16
47
559
5703
—
—
—
12
31
540
5641
14
86
464
4950
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
8.5e-01
—
—
—
—
2.1e+00
1.5e+00
cases:3.13%
controls:1.36%
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.21%
cases:2.30%
controls:0.52%
18
78
557
5672
—
—
—
—
9
12
543
5660
11
26
467
5010
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.5e-01
1.3e+00
1.5e+00
—
1.4e+00
1.5e+00
7.8e-01
cases:1.57%
controls:1.36%
cases:2.61%
controls:0.73%
cases:1.39%
controls:0.31%
—
—
cases:1.57%
controls:0.38%
cases:4.35%
controls:1.00%
cases:5.65%
controls:2.68%
9
78
566
5672
15
42
560
5708
8
18
567
5732
—
9
22
565
5724
24
57
528
5615
27
135
451
4901
Urology
34 [38004474]
34 [38004474]
4.0e-01
2.0e-01
5.8e-01
—
1.5e+00
1.1e+00
9.1e-01
cases:7.48%
controls:5.15%
cases:3.48%
controls:2.87%
cases:0.87%
controls:0.49%
—
—
cases:2.09%
controls:0.45%
cases:7.25%
controls:2.50%
cases:11.72%
controls:5.08%
43
296
532
5454
20
165
555
5585
5
28
570
5722
—
12
26
562
5720
40
142
512
5530
56
256
422
4780
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
4.1e-01
9.8e-01
1.6e+00
1.0e+50
—
4.6e-01
9.8e-01
cases:7.83%
controls:5.34%
cases:5.57%
controls:2.17%
cases:1.74%
controls:0.37%
cases:1.57%
controls:0.00%
—
—
cases:3.44%
controls:2.20%
cases:13.18%
controls:5.38%
45
307
530
5443
32
125
543
5625
10
21
565
5729
9
0
566
5750
—
19
125
533
5547
63
271
415
4765
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
24108-3 [3022914]
6.7e-01
1.6e+00
—
—
—
1.9e+00
7.9e-01
cases:1.04%
controls:0.54%
cases:1.57%
controls:0.33%
—
—
—
—
—
—
cases:1.81%
controls:0.26%
cases:1.26%
controls:0.58%
6
31
569
5719
9
19
566
5731
—
—
—
10
15
542
5657
6
29
472
5007
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
4.0e-01
6.2e-01
—
-1.0e+50
1.4e+00
5.0e-01
6.1e-01
cases:30.43%
controls:22.70%
cases:11.13%
controls:6.30%
—
—
cases:0.00%
controls:0.09%
cases:2.09%
controls:0.54%
cases:10.69%
controls:6.75%
cases:32.85%
controls:21.07%
175
1305
400
4445
64
362
511
5388
—
0
5
575
5745
12
31
562
5715
59
383
493
5289
157
1061
321
3975
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
5.1e-01
8.9e-01
9.9e-01
—
1.0e+00
8.7e-01
7.0e-01
cases:9.57%
controls:5.98%
cases:8.00%
controls:3.44%
cases:2.26%
controls:0.85%
—
—
cases:2.44%
controls:0.89%
cases:7.79%
controls:3.40%
cases:14.23%
controls:7.63%
55
344
520
5406
46
198
529
5552
13
49
562
5701
—
14
51
560
5695
43
193
509
5479
68
384
410
4652
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
3.8e-01
7.7e-01
2.1e+00
—
—
2.0e-01
5.6e-01
cases:11.13%
controls:7.90%
cases:4.87%
controls:2.31%
cases:1.39%
controls:0.17%
—
—
—
—
cases:3.08%
controls:2.54%
cases:13.81%
controls:8.42%
64
454
511
5296
28
133
547
5617
8
10
567
5740
—
—
17
144
535
5528
66
424
412
4612
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
6.8e-01
8.9e-01
2.3e+00
1.0e+50
1.7e+00
1.1e+00
6.3e-01
cases:3.30%
controls:1.70%
cases:2.26%
controls:0.94%
cases:1.39%
controls:0.14%
cases:1.04%
controls:0.00%
cases:0.87%
controls:0.16%
cases:3.62%
controls:1.23%
cases:6.49%
controls:3.55%
19
98
556
5652
13
54
562
5696
8
8
567
5742
6
0
569
5750
5
9
569
5737
20
70
532
5602
31
179
447
4857
moxonidine; oral
C02AC05 [21600401]
C02AC05 [21600401]
1.5e+00
1.9e+00
—
—
—
—
1.1e+00
cases:2.09%
controls:0.45%
cases:1.22%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.36%
12
26
563
5724
7
11
568
5739
—
—
—
—
5
18
473
5018
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
—
1.8e+00
—
—
—
1.6e+00
7.1e-01
—
—
cases:2.61%
controls:0.45%
—
—
—
—
—
—
cases:2.17%
controls:0.44%
cases:2.51%
controls:1.25%
—
15
26
560
5724
—
—
—
12
25
540
5647
12
63
466
4973
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
—
1.7e+00
—
—
—
1.7e+00
6.3e-01
—
—
cases:2.96%
controls:0.57%
—
—
—
—
—
—
cases:2.17%
controls:0.41%
cases:2.72%
controls:1.47%
—
17
33
558
5717
—
—
—
12
23
540
5649
13
74
465
4962
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
2.9e-01
1.3e+00
2.0e+00
—
1.5e+00
1.3e+00
5.6e-01
cases:1.39%
controls:1.04%
cases:2.09%
controls:0.59%
cases:1.04%
controls:0.14%
—
—
cases:0.87%
controls:0.19%
cases:1.99%
controls:0.56%
cases:2.30%
controls:1.33%
8
60
567
5690
12
34
563
5716
6
8
569
5742
—
5
11
569
5735
11
32
541
5640
11
67
467
4969
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
14920-3 [3008486]
-2.1e-02
4.7e-01
1.6e+00
—
1.2e+00
2.7e-01
1.8e-01
cases:21.57%
controls:21.93%
cases:17.22%
controls:11.50%
cases:7.48%
controls:1.55%
—
—
cases:4.53%
controls:1.43%
cases:14.13%
controls:11.14%
cases:31.38%
controls:27.64%
124
1261
451
4489
99
661
476
5089
43
89
532
5661
—
26
82
548
5664
78
632
474
5040
150
1392
328
3644
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
1.4e+00
1.3e+00
—
—
—
1.9e+00
7.2e-01
cases:2.96%
controls:0.78%
cases:1.57%
controls:0.42%
—
—
—
—
—
—
cases:1.81%
controls:0.28%
cases:1.46%
controls:0.71%
17
45
558
5705
9
24
566
5726
—
—
—
10
16
542
5656
7
36
471
5000
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
5.0e-01
1.5e+00
—
—
—
1.7e+00
6.0e-01
cases:1.91%
controls:1.17%
cases:2.96%
controls:0.68%
—
—
—
—
—
—
cases:3.26%
controls:0.60%
cases:3.56%
controls:1.99%
11
67
564
5683
17
39
558
5711
—
—
—
18
34
534
5638
17
100
461
4936
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
2742-5 [3034780]
1.0e+00
1.6e+00
1.0e+50
—
—
1.9e+00
1.3e+00
cases:2.26%
controls:0.83%
cases:1.22%
controls:0.24%
cases:1.22%
controls:0.00%
—
—
—
—
cases:1.45%
controls:0.23%
cases:2.72%
controls:0.75%
13
48
562
5702
7
14
568
5736
7
0
568
5750
—
—
8
13
544
5659
13
38
465
4998
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
7.3e-01
7.2e-01
6.7e-01
—
9.9e-01
7.1e-01
4.2e-01
cases:9.74%
controls:4.94%
cases:8.17%
controls:4.14%
cases:2.26%
controls:1.17%
—
—
cases:3.31%
controls:1.25%
cases:8.15%
controls:4.20%
cases:10.25%
controls:6.99%
56
284
519
5466
47
238
528
5512
13
67
562
5683
—
19
72
555
5674
45
238
507
5434
49
352
429
4684
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
-2.1e-01
—
—
—
—
1.9e+00
1.2e+00
cases:1.04%
controls:1.29%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.19%
cases:2.51%
controls:0.73%
6
74
569
5676
—
—
—
—
7
11
545
5661
12
37
466
4999
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
—
1.6e+00
—
—
—
1.5e+00
7.9e-01
—
—
cases:2.96%
controls:0.61%
—
—
—
—
—
—
cases:1.99%
controls:0.44%
cases:2.72%
controls:1.25%
—
17
35
558
5715
—
—
—
11
25
541
5647
13
63
465
4973
Other obesity
E66.8 [45533036]
E66.8 [45533036]
8.3e-01
—
—
—
—
1.8e+00
1.3e+00
cases:1.39%
controls:0.61%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.21%
cases:2.93%
controls:0.83%
8
35
567
5715
—
—
—
—
7
12
545
5660
14
42
464
4994
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
7.6e-01
1.1e+00
—
—
—
1.9e+00
1.2e+00
cases:2.96%
controls:1.41%
cases:2.09%
controls:0.70%
—
—
—
—
—
—
cases:1.27%
controls:0.19%
cases:2.72%
controls:0.87%
17
81
558
5669
12
40
563
5710
—
—
—
7
11
545
5661
13
44
465
4992
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
1.1e+00
1.9e+00
—
—
—
1.1e+00
8.5e-01
cases:2.26%
controls:0.75%
cases:2.09%
controls:0.31%
—
—
—
—
—
—
cases:1.45%
controls:0.49%
cases:2.30%
controls:0.99%
13
43
562
5707
12
18
563
5732
—
—
—
8
28
544
5644
11
50
467
4986
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
Z03.80 [2000503756]
1.5e+00
3.0e+00
—
—
—
—
1.7e+00
cases:1.22%
controls:0.26%
cases:1.74%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.26%
7
15
568
5735
10
5
565
5745
—
—
—
—
7
13
471
5023
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
—
1.5e+00
—
—
—
1.5e+00
6.1e-01
—
—
cases:2.61%
controls:0.59%
—
—
—
—
—
—
cases:1.99%
controls:0.46%
cases:2.72%
controls:1.49%
—
15
34
560
5716
—
—
—
11
26
541
5646
13
75
465
4961
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
5.0e-01
1.2e+00
—
1.0e+50
—
1.7e+00
1.3e+00
cases:2.96%
controls:1.81%
cases:1.39%
controls:0.42%
—
—
cases:0.87%
controls:0.00%
—
—
cases:2.17%
controls:0.41%
cases:4.60%
controls:1.31%
17
104
558
5646
8
24
567
5726
—
5
0
570
5750
—
12
23
540
5649
22
66
456
4970
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
1.4e-01
—
—
—
—
1.8e+00
1.2e+00
cases:1.04%
controls:0.90%
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.25%
cases:3.97%
controls:1.25%
6
52
569
5698
—
—
—
—
8
14
544
5658
19
63
459
4973
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
5.6e-01
1.0e+00
—
—
—
1.0e+00
8.8e-01
cases:5.04%
controls:2.96%
cases:3.48%
controls:1.27%
—
—
—
—
—
—
cases:3.44%
controls:1.25%
cases:10.46%
controls:4.61%
29
170
546
5580
20
73
555
5677
—
—
—
19
71
533
5601
50
232
428
4804
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
9.1e-01
1.0e+00
—
—
—
2.0e+00
5.4e-01
cases:3.65%
controls:1.50%
cases:2.43%
controls:0.90%
—
—
—
—
—
—
cases:4.17%
controls:0.58%
cases:3.14%
controls:1.85%
21
86
554
5664
14
52
561
5698
—
—
—
23
33
529
5639
15
93
463
4943
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
5.1e-01
2.6e-01
1.4e+00
—
7.7e-01
5.0e-01
5.6e-01
cases:26.26%
controls:17.63%
cases:10.43%
controls:8.26%
cases:3.48%
controls:0.92%
—
—
cases:1.74%
controls:0.82%
cases:11.78%
controls:7.51%
cases:32.85%
controls:21.84%
151
1014
424
4736
60
475
515
5275
20
53
555
5697
—
10
47
564
5699
65
426
487
5246
157
1100
321
3936
Biopsy of vaginal cervix
LDA20 [2001306656]
LDA20 [2001306656]
—
—
—
1.0e+50
—
1.0e+50
2.9e+00
—
—
—
—
—
—
cases:2.78%
controls:0.00%
—
—
cases:0.91%
controls:0.00%
cases:2.09%
controls:0.12%
—
—
—
16
0
559
5750
—
5
0
547
5672
10
6
468
5030
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
ZXE11 [2001311402]
1.0e+00
—
—
—
—
—
1.8e+00
cases:2.96%
controls:1.10%
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.24%
17
63
558
5687
—
—
—
—
—
7
12
471
5024
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
6.7e-01
1.2e+00
—
—
7.8e-01
8.8e-01
9.4e-01
cases:5.74%
controls:3.01%
cases:3.65%
controls:1.18%
—
—
—
—
cases:0.87%
controls:0.40%
cases:3.08%
controls:1.30%
cases:5.65%
controls:2.28%
33
173
542
5577
21
68
554
5682
—
—
5
23
569
5723
17
74
535
5598
27
115
451
4921
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
5.3e-01
5.4e-01
—
—
—
1.2e+00
1.0e+00
cases:11.30%
controls:7.01%
cases:2.78%
controls:1.63%
—
—
—
—
—
—
cases:3.44%
controls:1.06%
cases:8.58%
controls:3.30%
65
403
510
5347
16
94
559
5656
—
—
—
19
60
533
5612
41
166
437
4870
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
2.4e-01
1.1e+00
—
—
—
1.6e+00
1.1e+00
cases:1.57%
controls:1.23%
cases:1.04%
controls:0.35%
—
—
—
—
—
—
cases:1.81%
controls:0.37%
cases:3.14%
controls:1.03%
9
71
566
5679
6
20
569
5730
—
—
—
10
21
542
5651
15
52
463
4984
Oxygen content in Venous blood
19220-3 [3011648]
19220-3 [3011648]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.93%
controls:0.20%
—
—
—
—
—
—
14
10
464
5026
Hypertension secondary to other renal disorders
I15.1 [45557535]
I15.1 [45557535]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.10%
—
—
—
—
—
—
7
5
471
5031
Rheumatology
66 [38004491]
66 [38004491]
4.6e-01
9.8e-01
—
—
1.2e+00
8.6e-01
8.6e-01
cases:5.22%
controls:3.37%
cases:4.70%
controls:1.81%
—
—
—
—
cases:1.05%
controls:0.31%
cases:4.53%
controls:1.97%
cases:7.32%
controls:3.24%
30
194
545
5556
27
104
548
5646
—
—
6
18
568
5728
25
112
527
5560
35
163
443
4873
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
4.8e-02
8.1e-01
1.9e+00
—
—
7.2e-01
7.4e-01
cases:3.83%
controls:3.65%
cases:2.96%
controls:1.34%
cases:1.57%
controls:0.23%
—
—
—
—
cases:3.26%
controls:1.62%
cases:9.62%
controls:4.83%
22
210
553
5540
17
77
558
5673
9
13
566
5737
—
—
18
92
534
5580
46
243
432
4793
Radical radiotherapy
WF002 [2001310701]
WF002 [2001310701]
9.2e-01
1.4e+00
—
—
—
2.7e+00
—
cases:0.87%
controls:0.35%
cases:0.87%
controls:0.21%
—
—
—
—
—
—
cases:1.27%
controls:0.09%
—
—
5
20
570
5730
5
12
570
5738
—
—
—
7
5
545
5667
—
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
4.5e-01
5.4e-01
—
—
—
1.4e+00
1.3e+00
cases:3.30%
controls:2.14%
cases:1.57%
controls:0.92%
—
—
—
—
—
—
cases:2.36%
controls:0.62%
cases:5.02%
controls:1.41%
19
123
556
5627
9
53
566
5697
—
—
—
13
35
539
5637
24
71
454
4965
Other and unspecified cirrhosis of liver
K74.6 [45538546]
K74.6 [45538546]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.12%
—
—
—
—
—
—
8
6
470
5030
fluticasone; inhalant
R03BA05 [21603288]
R03BA05 [21603288]
5.2e-01
8.9e-01
5.5e-01
—
1.2e+00
8.9e-01
8.8e-01
cases:5.22%
controls:3.17%
cases:3.48%
controls:1.46%
cases:0.87%
controls:0.50%
—
—
cases:1.05%
controls:0.31%
cases:3.44%
controls:1.45%
cases:6.28%
controls:2.70%
30
182
545
5568
20
84
555
5666
5
29
570
5721
—
6
18
568
5728
19
82
533
5590
30
136
448
4900
dydrogesterone; oral
G03DB01 [21602544]
G03DB01 [21602544]
6.5e-01
2.0e-01
—
—
—
1.4e+00
1.2e+00
cases:3.13%
controls:1.65%
cases:0.87%
controls:0.71%
—
—
—
—
—
—
cases:1.81%
controls:0.44%
cases:3.77%
controls:1.13%
18
95
557
5655
5
41
570
5709
—
—
—
10
25
542
5647
18
57
460
4979
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
15081-3 [3021387]
8.1e-01
1.6e+00
—
—
—
1.2e+00
1.1e+00
cases:1.74%
controls:0.78%
cases:1.74%
controls:0.37%
—
—
—
—
—
—
cases:0.91%
controls:0.28%
cases:2.72%
controls:0.95%
10
45
565
5705
10
21
565
5729
—
—
—
5
16
547
5656
13
48
465
4988
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
9.9e-01
1.0e+00
—
—
—
1.7e+00
7.4e-01
cases:3.48%
controls:1.32%
cases:1.57%
controls:0.56%
—
—
—
—
—
—
cases:1.81%
controls:0.35%
cases:2.30%
controls:1.11%
20
76
555
5674
9
32
566
5718
—
—
—
10
20
542
5652
11
56
467
4980
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
9.9e-01
1.0e+00
—
—
—
1.7e+00
7.4e-01
cases:3.48%
controls:1.32%
cases:1.57%
controls:0.56%
—
—
—
—
—
—
cases:1.81%
controls:0.35%
cases:2.30%
controls:1.11%
20
76
555
5674
9
32
566
5718
—
—
—
10
20
542
5652
11
56
467
4980
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
2.6e+00
—
—
—
—
—
1.8e+00
cases:1.39%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.18%
8
6
567
5744
—
—
—
—
—
5
9
473
5027
Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
1779-8 [3035400]
1779-8 [3035400]
2.6e+00
—
—
—
—
—
—
cases:1.39%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
8
6
567
5744
—
—
—
—
—
—
Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
33421-9 [3045684]
33421-9 [3045684]
2.6e+00
—
—
—
—
—
—
cases:1.39%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
8
6
567
5744
—
—
—
—
—
—
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
—
1.5e+00
—
—
—
1.1e+00
3.7e-01
—
—
cases:3.48%
controls:0.82%
—
—
—
—
—
—
cases:2.36%
controls:0.78%
cases:2.72%
controls:1.89%
—
20
47
555
5703
—
—
—
13
44
539
5628
13
95
465
4941
Difficulties in perfomrming procedure
ZXD30 [2001311389]
ZXD30 [2001311389]
1.3e+00
—
—
—
—
—
2.6e+00
cases:1.39%
controls:0.38%
—
—
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.16%
8
22
567
5728
—
—
—
—
—
10
8
468
5028
hydroxycarbamide; oral
L01XX05 [21603787]
L01XX05 [21603787]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.10%
—
—
—
—
—
—
6
5
472
5031
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
11253-2 [3026250]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.10%
—
—
—
—
—
—
6
5
472
5031
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
6.3e-01
6.7e-01
3.9e-01
—
4.9e-01
6.6e-01
5.7e-01
cases:12.35%
controls:6.97%
cases:8.17%
controls:4.37%
cases:2.09%
controls:1.43%
—
—
cases:1.92%
controls:1.18%
cases:8.15%
controls:4.37%
cases:11.51%
controls:6.85%
71
401
504
5349
47
251
528
5499
12
82
563
5668
—
11
68
563
5678
45
248
507
5424
55
345
423
4691
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
1.2e+00
1.1e+00
—
—
—
1.4e+00
1.3e+00
cases:3.48%
controls:1.03%
cases:0.87%
controls:0.30%
—
—
—
—
—
—
cases:1.27%
controls:0.32%
cases:2.72%
controls:0.77%
20
59
555
5691
5
17
570
5733
—
—
—
7
18
545
5654
13
39
465
4997
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
1.2e+00
1.3e+00
—
—
—
1.3e+00
1.4e+00
cases:2.61%
controls:0.83%
cases:1.57%
controls:0.45%
—
—
—
—
—
—
cases:1.27%
controls:0.35%
cases:2.51%
controls:0.66%
15
48
560
5702
9
26
566
5724
—
—
—
7
20
545
5652
12
33
466
5003
Ocular fundus photography for diabetic retinopathy screening
CL2S4 [2001301465]
CL2S4 [2001301465]
2.5e+00
—
—
—
—
-1.0e+50
—
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
6
5
569
5745
—
—
—
—
0
5
552
5667
—
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
F32.11 [2000501981]
1.1e+00
2.5e+00
—
—
—
—
1.4e+00
cases:0.87%
controls:0.28%
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.32%
5
16
570
5734
6
5
569
5745
—
—
—
—
6
16
472
5020
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
17792-3 [3023939]
1.6e+00
2.5e+00
—
—
—
—
—
cases:1.04%
controls:0.21%
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
6
12
569
5738
6
5
569
5745
—
—
—
—
—
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
8.9e-01
2.5e+00
—
—
—
—
—
cases:1.39%
controls:0.57%
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
8
33
567
5717
6
5
569
5745
—
—
—
—
—
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
14913-8 [3017446]
3.6e-01
1.4e+00
2.5e+00
—
—
9.9e-01
4.3e-01
cases:1.74%
controls:1.22%
cases:1.57%
controls:0.38%
cases:1.04%
controls:0.09%
—
—
—
—
cases:1.27%
controls:0.48%
cases:3.14%
controls:2.07%
10
70
565
5680
9
22
566
5728
6
5
569
5745
—
—
7
27
545
5645
15
104
463
4932
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
-5.4e-01
1.4e+00
—
—
—
1.1e+00
3.4e-01
cases:0.87%
controls:1.48%
cases:3.48%
controls:0.89%
—
—
—
—
—
—
cases:2.54%
controls:0.86%
cases:3.35%
controls:2.40%
5
85
570
5665
20
51
555
5699
—
—
—
14
49
538
5623
16
121
462
4915
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
-5.4e-01
1.4e+00
—
—
—
1.1e+00
3.7e-01
cases:0.87%
controls:1.48%
cases:3.48%
controls:0.89%
—
—
—
—
—
—
cases:2.54%
controls:0.86%
cases:3.35%
controls:2.34%
5
85
570
5665
20
51
555
5699
—
—
—
14
49
538
5623
16
118
462
4918
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
-5.4e-01
1.4e+00
—
—
—
1.1e+00
3.4e-01
cases:0.87%
controls:1.48%
cases:3.48%
controls:0.89%
—
—
—
—
—
—
cases:2.54%
controls:0.86%
cases:3.35%
controls:2.40%
5
85
570
5665
20
51
555
5699
—
—
—
14
49
538
5623
16
121
462
4915
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
5.1e-01
6.7e-01
2.5e+00
—
—
2.0e-01
4.4e-01
cases:6.09%
controls:3.74%
cases:2.26%
controls:1.17%
cases:1.22%
controls:0.10%
—
—
—
—
cases:1.63%
controls:1.34%
cases:6.69%
controls:4.41%
35
215
540
5535
13
67
562
5683
7
6
568
5744
—
—
9
76
543
5596
32
222
446
4814
Electrophysiological examination of eye
XCD10 [2001300413]
XCD10 [2001300413]
2.4e+00
—
—
—
—
—
1.8e+00
cases:1.39%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.22%
8
7
567
5743
—
—
—
—
—
6
11
472
5025
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
-5.4e-01
1.4e+00
—
—
—
1.0e+00
3.7e-01
cases:0.87%
controls:1.48%
cases:3.48%
controls:0.92%
—
—
—
—
—
—
cases:2.54%
controls:0.92%
cases:3.35%
controls:2.34%
5
85
570
5665
20
53
555
5697
—
—
—
14
52
538
5620
16
118
462
4918
Ulcerative colitis and Crohn's disease
208 [2001600206]
208 [2001600206]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.14%
—
—
—
—
—
—
7
7
471
5029
Other hypertrophic cardiomyopathy
I42.2 [45567175]
I42.2 [45567175]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.12%
—
—
—
—
—
—
6
6
472
5030
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
7.7e-01
—
—
—
—
2.3e+00
1.8e+00
cases:1.04%
controls:0.49%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.12%
cases:1.26%
controls:0.22%
6
28
569
5722
—
—
—
—
7
7
545
5665
6
11
472
5025
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
F33.4 [45533100]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.09%
controls:0.11%
—
—
—
—
—
—
—
6
6
546
5666
—
Nutritional therapy
R4190 [2001310243]
R4190 [2001310243]
1.5e+00
1.5e+00
—
—
—
2.3e+00
8.8e-01
cases:1.04%
controls:0.23%
cases:1.04%
controls:0.24%
—
—
—
—
—
—
cases:1.09%
controls:0.11%
cases:1.05%
controls:0.44%
6
13
569
5737
6
14
569
5736
—
—
—
6
6
546
5666
5
22
473
5014
Lumbar spine extensive MRI examination with high intensity magnet
NA3CG [2001307039]
NA3CG [2001307039]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.09%
—
—
—
—
—
—
—
5
5
547
5667
—
Erythrocyte sedimentation rate above reference range
165468009 [4013526]
165468009 [4013526]
-1.0e+50
—
—
—
—
2.3e+00
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.09%
—
—
0
9
575
5741
—
—
—
—
5
5
547
5667
—
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14688-6 [3016616]
14688-6 [3016616]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.09%
—
—
—
—
—
—
—
5
5
547
5667
—
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
6.0e-01
5.0e-01
—
—
—
1.2e+00
1.1e+00
cases:3.83%
controls:2.14%
cases:1.57%
controls:0.96%
—
—
—
—
—
—
cases:2.17%
controls:0.63%
cases:6.07%
controls:2.14%
22
123
553
5627
9
55
566
5695
—
—
—
12
36
540
5636
29
108
449
4928
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
6.3e-01
1.2e+00
1.2e+00
—
1.2e+00
1.1e+00
5.6e-01
cases:2.61%
controls:1.41%
cases:3.13%
controls:0.96%
cases:1.04%
controls:0.31%
—
—
cases:1.05%
controls:0.31%
cases:2.90%
controls:0.97%
cases:2.93%
controls:1.69%
15
81
560
5669
18
55
557
5695
6
18
569
5732
—
6
18
568
5728
16
55
536
5617
14
85
464
4951
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
—
2.3e+00
—
—
—
1.7e+00
—
—
—
cases:1.04%
controls:0.10%
—
—
—
—
—
—
cases:0.91%
controls:0.16%
—
—
—
6
6
569
5744
—
—
—
5
9
547
5663
—
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
4533-6 [3024403]
—
2.3e+00
—
—
—
—
1.4e+00
—
—
cases:1.04%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.26%
—
6
6
569
5744
—
—
—
—
5
13
473
5023
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
5.8e-01
1.0e+00
—
—
1.5e+00
1.2e+00
7.8e-01
cases:2.78%
controls:1.58%
cases:2.61%
controls:0.94%
—
—
—
—
cases:1.05%
controls:0.23%
cases:2.72%
controls:0.83%
cases:4.18%
controls:1.97%
16
91
559
5659
15
54
560
5696
—
—
6
13
568
5733
15
47
537
5625
20
99
458
4937
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
3.3e-01
4.1e-01
1.6e+00
—
1.1e+00
5.3e-01
6.1e-01
cases:6.09%
controls:4.47%
cases:3.30%
controls:2.23%
cases:1.91%
controls:0.38%
—
—
cases:1.22%
controls:0.42%
cases:4.17%
controls:2.49%
cases:9.83%
controls:5.58%
35
257
540
5493
19
128
556
5622
11
22
564
5728
—
7
24
567
5722
23
141
529
5531
47
281
431
4755
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
2.4e-01
7.2e-01
—
—
—
1.3e+00
8.8e-01
cases:5.39%
controls:4.28%
cases:1.74%
controls:0.85%
—
—
—
—
—
—
cases:2.90%
controls:0.78%
cases:6.07%
controls:2.60%
31
246
544
5504
10
49
565
5701
—
—
—
16
44
536
5628
29
131
449
4905
Sepsis, unspecified
A41.9 [45585911]
A41.9 [45585911]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.14%
—
—
—
—
—
—
6
7
472
5029
Other ulcerative colitis
K51.8 [45586720]
K51.8 [45586720]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.14%
0
9
575
5741
—
—
—
—
—
6
7
472
5029
tacrolimus; oral, parenteral
L04AD02 [21603925]
L04AD02 [21603925]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.14%
—
—
—
—
—
—
6
7
472
5029
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
3.9e-01
7.1e-01
3.6e-01
—
8.0e-01
8.7e-01
6.3e-01
cases:12.17%
controls:8.61%
cases:8.35%
controls:4.28%
cases:1.39%
controls:0.97%
—
—
cases:2.44%
controls:1.11%
cases:9.06%
controls:4.00%
cases:14.44%
controls:8.28%
70
495
505
5255
48
246
527
5504
8
56
567
5694
—
14
64
560
5682
50
227
502
5445
69
417
409
4619
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
3.9e-01
1.5e+00
—
—
—
2.2e+00
8.6e-01
cases:0.87%
controls:0.59%
cases:1.04%
controls:0.23%
—
—
—
—
—
—
cases:1.27%
controls:0.14%
cases:1.26%
controls:0.54%
5
34
570
5716
6
13
569
5737
—
—
—
7
8
545
5664
6
27
472
5009
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
F33.11 [2000501985]
1.5e+00
—
-1.0e+50
—
—
2.2e+00
1.7e+00
cases:0.87%
controls:0.19%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.27%
controls:0.14%
cases:1.26%
controls:0.24%
5
11
570
5739
—
0
5
575
5745
—
—
7
8
545
5664
6
12
472
5024
Recurrent depressive disorder, unspecified
F33.9 [45581458]
F33.9 [45581458]
1.1e+00
—
—
—
—
2.2e+00
9.5e-01
cases:1.39%
controls:0.47%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.14%
cases:1.88%
controls:0.73%
8
27
567
5723
—
—
—
—
7
8
545
5664
9
37
469
4999
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 [3001467]
1777-2 [3001467]
2.2e+00
2.3e+00
—
—
—
—
—
cases:1.39%
controls:0.16%
cases:0.87%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
8
9
567
5741
5
5
570
5745
—
—
—
—
—
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
150
584
3.12
28.89
4.1
2.5
8.97
7.40
umol/l
0.39
140
512
354
2146
2.68
28.78
9.0
4.8
35.45
36.18
g/l
1.62
338
2027
436
2944
2.97
28.49
16.3
9.8
4.01
4.07
e9/l
0.22
366
2551
247
1278
2.63
27.53
7.7
3.8
83.05
91.63
%
4.89
240
1256
361
2246
2.62
27.23
10.5
6.6
1.21
1.21
mmol/l
0.38
345
2081
187
855
2.76
26.54
4.2
2.4
12.77
13.29
umol/l
0.40
177
800
168
731
2.83
26.18
4.4
2.4
22.98
22.71
%
0.08
158
688
385
2507
2.61
25.80
11.0
7.3
1.21
1.21
mmol/l
0.11
338
2178
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
57
123
5.03
25.33
3.3
2.7
0.35
0.35
iu/ml
0.00
22
65
173
797
2.67
23.84
4.3
2.4
2.28
2.36
g/l
0.96
163
740
181
855
2.63
23.69
4.6
3.7
0.79
0.82
mmol/l
1.75
164
813
358
2310
2.45
23.56
16.5
11.1
0.00
0.00
e9/l
0.49
277
1880
115
438
3.03
22.57
3.7
2.7
11.65
10.21
g/l
1.87
108
408
178
866
2.53
21.64
4.5
2.9
0.95
0.96
e6/l
0.02
84
426
118
471
2.89
21.20
3.5
2.3
0.22
0.22
g/l
0.08
112
442
122
499
2.83
20.93
4.6
2.4
41.08
37.61
u/l
0.19
103
413
55
136
4.36
20.64
3.7
2.2
0.02
0.04
g/l
0.16
55
128
147
667
2.62
20.54
10.4
5.8
1.06
1.05
mmol/l
0.21
141
620
245
1400
2.30
20.52
4.8
3.1
0.27
0.39
e6/l
0.98
171
1011
166
800
2.51
20.44
4.6
3.0
3.67
2.70
e6/l
0.45
70
362
218
1196
2.32
19.99
1.7
1.5
2.81
2.32
g/l
1.82
150
748
54
135
4.31
19.97
3.7
2.2
0.00
0.00
g/l
-0.00
54
120
386
2686
2.32
19.78
10.3
6.3
12.28
11.12
umol/l
1.29
373
2557
285
1773
2.20
18.99
4.9
3.2
35.19
29.89
u/l
1.82
274
1678
51
130
4.21
18.37
4.1
3.5
2.56
2.98
ratio
0.15
24
81
489
3842
2.79
18.21
14.6
7.9
88.04
78.97
u/l
1.90
474
3632
54
146
3.98
17.97
4.0
3.7
32.53
46.00
mg/l
0.43
47
127
54
146
3.98
17.97
4.0
3.7
68.83
90.62
mg/l
0.19
47
127
67
211
3.46
17.85
2.0
2.3
1.45
1.45
g/l
0.01
52
190
324
2164
2.13
17.49
2.5
2.1
97.80
96.19
pmol/l
0.23
165
1114
239
1421
2.16
17.49
3.3
3.4
2257.64
1185.75
ng/l
0.59
215
1214
274
1735
2.10
16.83
5.4
3.3
2.36
2.36
mmol/l
0.12
255
1580
262
1635
2.10
16.70
4.8
3.2
55.50
53.75
e6/l
0.03
187
1241
293
1912
2.08
16.50
6.1
3.9
46.19
114.34
e6/l
1.68
198
1313
58
181
3.45
15.64
1.6
1.4
—
—
—
0
0
322
2207
2.04
15.51
24.1
13.2
1.30
1.21
inr
1.87
271
1823
121
570
2.42
15.21
2.3
1.9
—
—
—
0
0
125
598
2.39
15.18
2.2
1.9
—
—
—
0
0
357
2563
2.03
14.82
4.9
3.1
131.77
101.59
ug/l
1.49
338
2403
174
972
2.13
14.44
3.6
2.6
2.46
2.45
mmol/l
1.03
158
873
93
396
2.61
14.44
7.2
4.0
105.88
80.86
ng/l
1.16
86
352
74
280
2.88
14.42
2.1
1.7
—
—
—
0
0
87
363
2.64
14.06
1.8
1.7
—
—
—
0
0
219
1352
2.00
13.72
1.3
1.3
1.03
1.57
u/ml
0.51
50
403
239
1528
1.96
13.48
2.9
2.2
188.64
241.35
u/l
0.50
229
1451
104
488
2.38
13.06
7.3
3.8
0.57
1.90
mmol/l
2.33
98
423
211
1305
1.97
13.01
3.9
2.7
341.49
337.73
umol/l
0.21
185
1163
168
962
2.05
12.84
4.7
3.8
243.60
388.36
ng/l
0.49
139
705
464
3761
2.19
12.70
6.5
4.3
14.10
11.22
mm/h
3.15
441
3505
199
1219
1.97
12.52
2.3
1.8
1.27
1.20
mg/l
0.10
161
951
146
808
2.08
12.16
2.4
1.9
—
—
—
0
0
324
2344
1.87
12.10
3.6
2.6
76.14
76.09
nmol/l
0.01
300
2126
210
1332
1.91
11.77
3.1
2.2
2.60
2.84
mg/l
0.63
185
1152
76
324
2.55
11.69
2.7
3.5
263.73
169.31
ng/l
0.58
66
294
90
421
2.35
11.31
14.9
7.6
10.27
8.90
mmol/l
1.09
84
405
196
1232
1.89
11.19
4.2
2.3
—
—
—
0
0
37
109
3.56
10.88
8.8
7.1
502.40
254.00
iu/ml
—
5
12
378
2945
1.82
10.36
8.3
5.1
6.63
6.58
mmol/l
0.20
368
2763
426
3468
1.87
9.84
4.8
3.3
61.77
44.25
u/l
2.77
403
3297
23
54
4.39
9.20
1.5
1.2
120.75
52.14
u/l
0.82
23
48
101
537
2.07
9.17
8.9
9.2
-0.94
0.90
mmol/l
3.13
87
458
349
2708
1.73
9.16
4.6
3.8
0.00
0.00
estimate
0.50
67
558
58
245
2.52
9.07
2.1
1.8
8.28
5.84
iu/ml
—
10
53
33
102
3.37
9.03
1.9
1.4
—
—
—
0
0
353
2757
1.72
8.96
4.8
3.9
0.00
0.57
estimate
0.52
65
543
349
2732
1.70
8.64
4.7
3.9
0.00
6.13
estimate
0.80
68
571
33
106
3.24
8.51
1.5
1.5
151.55
153.45
au/ml
0.03
11
39
101
552
2.01
8.47
9.2
9.0
4.95
5.12
kpa
1.14
95
536
101
552
2.01
8.47
9.2
9.0
12.47
12.44
kpa
0.01
93
537
18
37
4.99
8.41
1.4
3.3
945.56
1011.43
mg
0.06
18
37
210
1446
1.71
8.34
2.1
1.7
21.61
20.25
nmol/l
0.62
188
1232
34
114
3.11
8.18
1.8
1.4
—
—
—
0
0
227
1605
1.68
8.12
4.1
2.5
62.75
63.25
u/l
0.02
209
1492
547
4980
2.89
8.01
31.4
17.6
139.35
139.68
mmol/l
2.40
541
4881
170
1118
1.74
7.90
3.2
2.6
5.26
6.46
e6/l
0.45
154
1034
547
4986
2.87
7.87
32.2
17.7
3.96
3.96
mmol/l
0.11
541
4874
310
2396
1.63
7.68
4.4
2.8
—
—
estimate
—
0
0
29
92
3.27
7.64
1.4
1.3
—
—
—
0
0
544
4959
2.70
7.57
28.8
15.1
25.60
22.83
mg/l
1.08
473
4059
72
365
2.11
7.37
2.2
2.4
12.36
7.83
ug/l
0.89
63
324
36
133
2.82
7.33
3.3
2.9
3.88
2.66
index
0.46
17
74
481
4206
1.86
7.19
38.4
18.8
13.96
13.54
%
7.15
476
4165
36
135
2.78
7.13
1.3
1.5
—
—
—
0
0
52
234
2.34
7.10
1.4
1.2
0.18
1.93
u/ml
—
5
15
89
499
1.93
6.88
4.2
3.3
—
—
—
0
0
524
4739
2.15
6.76
27.0
14.3
82.65
83.87
ml/min/173m2
0.55
488
4357
28
94
3.08
6.74
4.4
3.9
—
3498.38
u/ml
—
0
8
18
45
4.10
6.67
1.3
1.3
695.70
2521.24
e6/l
—
10
25
119
739
1.77
6.63
2.8
2.4
119.94
115.22
ug/g
0.07
98
593
17
41
4.24
6.59
1.3
1.3
156793.75
23172.76
e6/l
—
8
17
85
478
1.91
6.51
4.5
4.3
4.33
30.29
ug/l
0.93
68
398
20
56
3.66
6.36
2.0
1.2
—
—
—
0
0
32
121
2.74
6.26
1.6
1.4
326.12
227.28
u/ml
0.62
24
64
33
127
2.70
6.24
1.5
1.4
—
—
—
0
0
70
374
1.99
6.21
2.3
2.4
14.64
20.40
au/ml
—
5
26
516
4669
1.99
6.20
6.9
5.5
1.81
1.89
mu/l
0.91
495
4341
28
99
2.92
6.18
3.0
2.0
4.59
5.05
mmol/24h
0.26
28
85
56
276
2.14
6.16
4.0
2.9
0.54
0.61
%
1.14
56
276
39
165
2.46
6.11
3.1
2.9
—
—
—
0
0
456
3990
1.68
6.00
5.7
4.5
14.57
14.70
pmol/l
0.52
438
3685
39
167
2.43
5.96
1.3
1.6
0.14
0.05
iu/ml
0.33
11
30
126
818
1.69
5.95
2.1
1.7
1112.90
1179.80
nmol/l
0.38
103
613
37
155
2.48
5.92
2.5
1.2
—
—
—
0
0
56
281
2.10
5.89
4.1
2.9
0.97
1.21
%
1.75
56
281
507
4585
1.87
5.75
7.8
6.2
38.96
38.98
mmol/mol
0.01
484
4322
25
88
2.92
5.58
1.3
1.2
8.29
2.20
u/ml
0.64
14
30
15
29
5.28
5.42
1.3
1.9
—
—
—
0
0
15
29
5.28
5.42
1.3
1.9
—
—
—
0
0
18
53
3.47
5.34
4.9
4.2
—
—
—
0
0
36
157
2.38
5.30
1.6
1.3
259.65
287.85
ug/g
0.33
23
82
14
28
5.10
4.97
3.4
2.9
852.29
660.39
u/ml
0.24
14
28
49
251
2.04
4.90
1.5
1.5
0.47
0.27
mg/l
0.62
21
102
20
68
3.01
4.76
1.0
1.0
—
—
—
0
0
223
1728
1.47
4.71
4.0
3.4
7.11
7.73
mmol/l
1.29
188
1480
24
91
2.71
4.71
1.3
1.2
6.60
3.85
u/ml
0.54
15
41
551
5193
2.35
4.61
19.8
11.7
29.16
25.71
u/l
2.96
543
5053
24
93
2.65
4.53
1.3
1.3
—
—
—
0
0
24
93
2.65
4.53
1.3
1.3
—
—
—
0
0
33
150
2.27
4.46
1.5
1.2
—
—
—
0
0
123
857
1.55
4.27
1.9
1.4
—
—
—
0
0
9
13
7.01
4.17
2.0
1.5
0.66
0.61
mmol/l
—
9
13
9
13
7.01
4.17
1.4
1.1
83.11
99.54
%
—
9
13
59
347
1.78
3.93
3.7
3.6
4.55
4.63
pmol/l
0.23
52
309
28
126
2.28
3.89
1.9
1.6
—
—
—
0
0
84
548
1.62
3.84
8.9
6.7
—
—
—
0
0
60
358
1.75
3.81
2.3
2.4
13.88
13.09
nmol/l
0.27
55
331
30
141
2.19
3.78
1.2
1.2
—
1.00
—
0
11
30
143
2.16
3.65
1.6
1.6
—
—
—
0
0
31
151
2.11
3.58
1.6
1.2
—
—
—
0
0
150
1127
1.45
3.56
1.8
1.7
—
—
—
0
0
384
3386
1.40
3.54
3.6
3.2
—
—
—
0
0
96
659
1.55
3.54
1.6
1.8
1.58
1.45
%
0.59
78
581
6
6
10.09
3.50
1.0
1.0
—
—
—
0
0
36
188
1.98
3.47
4.9
3.0
94.50
1950.38
u/ml
1.24
30
160
38
203
1.93
3.43
1.8
1.7
—
—
—
0
0
35
182
1.98
3.41
1.3
1.3
—
1.34
—
0
7
34
175
2.00
3.41
1.4
1.4
9.74
9.89
u/l
0.02
23
143
200
1597
1.39
3.34
4.9
4.2
20.16
9.06
mg/mmol
0.90
119
1003
29
142
2.10
3.32
1.3
1.2
38.00
32.18
u/ml
—
5
17
10
23
4.41
3.32
1.3
1.1
—
—
—
0
0
26
123
2.17
3.25
1.4
1.4
—
—
—
0
0
507
4740
1.57
3.18
5.6
5.0
6.02
5.88
mmol/l
1.23
474
4383
22
98
2.29
3.16
1.4
1.3
—
—
—
0
0
38
210
1.87
3.12
1.9
1.6
12.90
10.06
u/ml
—
8
41
14
50
2.84
3.10
1.5
1.6
—
—
—
0
0
20
87
2.35
3.04
1.1
1.1
—
—
—
0
0
11
31
3.60
3.00
1.8
2.4
0.64
0.84
index
0.54
11
31
29
148
2.01
3.00
1.2
1.1
—
—
—
0
0
29
149
2.00
2.95
1.2
1.1
—
—
—
0
0
17
70
2.47
2.90
1.8
1.4
—
—
—
0
0
16
64
2.54
2.89
1.5
1.4
—
—
—
0
0
9
22
4.14
2.89
1.1
1.5
—
—
—
0
0
27
137
2.02
2.85
1.6
1.6
—
—
—
0
0
5
6
8.39
2.75
1.0
1.5
—
—
—
0
0
6
10
6.05
2.70
1.7
1.2
0.28
0.56
ug/l
—
6
5
10
29
3.49
2.70
1.6
1.1
—
—
—
0
0
132
1015
1.39
2.70
1.3
1.3
23.45
31.62
iu/ml
0.58
37
307
41
245
1.72
2.64
2.0
1.5
324.26
296.51
mu/l
0.28
35
224
59
390
1.57
2.58
1.6
1.5
—
—
—
0
0
18
81
2.26
2.56
1.2
1.1
—
—
—
0
0
6
11
5.50
2.55
1.0
1.5
—
—
—
0
0
24
123
1.99
2.49
1.9
2.0
129.35
128.39
g/l
0.07
17
97
13
51
2.58
2.46
1.2
1.1
—
—
—
0
0
45
282
1.65
2.45
1.3
1.3
—
—
—
0
0
58
387
1.55
2.45
5.0
3.6
1.22
1.23
mmol/l
0.92
50
337
24
124
1.98
2.44
1.3
1.3
2.73
10.73
e6/l
0.76
11
92
63
430
1.52
2.41
1.2
1.3
68.29
128.26
u/ml
1.44
17
178
247
2117
1.29
2.36
2.3
1.9
1.42
1.34
mmol/l
0.73
208
1805
24
126
1.94
2.34
1.3
1.3
172.00
131.54
e6/l
0.10
14
96
223
1890
1.29
2.32
4.4
3.7
42.64
86.84
ng/l
0.58
146
1263
10
34
2.97
2.29
2.0
1.5
8.70
5.10
u/l
—
10
28
15
66
2.31
2.26
1.8
1.5
—
—
—
0
0
5
9
5.59
2.21
1.0
1.0
3.72
7.29
nmol/l
—
5
9
41
627
0.63
2.21
4.9
4.7
31.83
31.68
%
0.02
24
429
8
24
3.37
2.18
1.7
2.1
74.75
70.80
ug/l
—
8
24
24
130
1.88
2.15
1.4
1.3
—
—
—
0
0
556
5392
1.86
2.10
43.5
23.3
252.90
253.32
e9/l
0.04
548
5306
92
695
1.39
2.09
3.4
2.9
0.79
0.73
ug/l
0.27
59
421
10
37
2.73
2.08
1.2
1.1
—
—
—
0
0
556
5395
1.84
2.05
43.5
23.2
4.41
4.49
e12/l
2.69
543
5294
12
50
2.43
2.03
4.7
4.3
13.88
32.30
u/ml
—
5
17
18
90
2.03
2.02
5.8
3.5
24.06
18.88
u/ml
0.40
18
90
9
32
2.84
2.00
1.9
2.4
—
—
—
0
0
119
943
1.33
1.99
1.3
1.3
3.26
12.11
u/ml
2.79
41
376
56
392
1.47
1.93
4.7
2.6
55.89
71.14
ml/min/173m2
1.97
19
162
489
4637
1.36
1.90
4.7
4.2
1.32
1.27
mmol/l
0.93
462
4299
7
22
3.21
1.88
1.4
1.4
—
—
—
0
0
6
17
3.55
1.84
1.2
3.8
179.33
207.29
u/l
—
6
17
511
4886
1.40
1.82
5.7
5.0
4.51
4.66
mmol/l
2.79
491
4581
22
124
1.80
1.78
1.6
1.3
—
—
—
0
0
14
67
2.12
1.77
1.0
1.2
—
—
—
0
0
5
13
3.87
1.72
1.0
1.3
—
—
—
0
0
11
48
2.32
1.71
2.0
1.2
108.91
109.50
pmol/l
0.01
11
48
515
4940
1.40
1.71
6.4
5.6
2.62
2.73
mmol/l
2.07
490
4620
24
141
1.73
1.71
1.3
1.3
400.71
472.67
mg/l
0.66
24
135
508
4865
1.37
1.68
5.7
4.9
1.44
1.48
mmol/l
1.17
487
4541
33
213
1.58
1.66
1.2
1.3
290.60
241.87
miu/ml
—
10
103
87
678
1.33
1.64
2.6
2.1
—
—
—
0
0
113
916
1.29
1.61
4.1
4.5
24.37
21.51
%
0.91
44
411
13
63
2.09
1.61
1.7
1.2
—
—
—
0
0
15
77
1.97
1.60
1.7
1.3
—
—
—
0
0
42
289
1.49
1.60
3.8
3.9
2.02
1.65
mmol/l
0.17
31
218
7
26
2.71
1.58
1.1
1.3
—
—
—
0
0
12
57
2.13
1.56
1.7
1.2
—
—
—
0
0
18
100
1.83
1.54
1.3
1.4
—
—
—
0
0
8
33
2.44
1.54
1.1
1.2
—
—
—
0
0
25
154
1.65
1.52
1.1
1.3
—
—
—
0
0
11
51
2.18
1.51
1.7
1.2
—
—
—
0
0
11
51
2.18
1.51
1.7
1.2
—
—
—
0
0
41
286
1.47
1.48
1.3
1.4
28.99
23.21
iu/l
0.36
29
242
9
38
2.39
1.46
3.2
1.4
—
—
—
0
0
20
119
1.71
1.39
1.9
1.5
15385.58
14887.21
e6/l
0.02
12
85
11
53
2.10
1.39
1.7
1.2
—
—
—
0
0
11
53
2.10
1.39
1.7
1.2
—
—
—
0
0
29
191
1.55
1.37
1.5
1.4
—
—
—
0
0
14
75
1.89
1.35
1.4
1.3
347.56
330.13
pmol/l
—
9
67
10
47
2.15
1.34
1.1
1.0
—
—
—
0
0
8
35
2.30
1.27
1.1
1.1
—
—
—
0
0
122
1028
1.24
1.26
1.6
1.7
468.78
13341378.91
pmol/l
0.50
97
877
8
36
2.24
1.24
1.1
1.2
—
—
—
0
0
91
743
1.27
1.24
2.9
2.3
—
—
—
0
0
11
57
1.95
1.17
1.1
1.1
—
—
—
0
0
137
1179
1.21
1.16
5.4
4.9
4.40
1.84
ug/l
0.51
124
1063
15
87
1.74
1.16
1.9
1.7
—
—
—
0
0
5
20
2.51
1.15
1.2
1.8
0.56
0.46
e9/l
—
5
20
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
11
59
1.88
1.08
1.1
1.1
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
13
77
1.70
0.96
1.5
1.5
—
—
—
0
0
9
51
1.78
0.95
1.8
1.9
—
—
—
0
0
34
252
1.37
0.94
1.8
1.5
—
—
—
0
0
167
1492
1.17
0.92
5.0
4.0
0.00
0.01
estimate
0.99
64
530
17
110
1.56
0.91
2.1
2.4
109.88
71.83
ug/min
—
8
61
8
42
1.92
0.89
1.3
1.0
177.38
239.11
mg/l
—
8
36
8
42
1.92
0.89
2.4
1.7
—
—
—
0
0
10
56
1.80
0.88
1.0
1.1
—
—
—
0
0
6
31
1.95
0.84
1.3
1.5
—
—
—
0
0
13
202
0.64
0.84
1.1
1.1
1.58
1.56
g/l
0.12
13
202
24
172
1.41
0.82
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
6
34
1.77
0.76
1.7
1.4
—
—
—
0
0
14
91
1.55
0.75
2.9
2.8
11.18
8.37
pmol/l
0.27
14
91
5
24
2.09
0.74
1.4
1.3
—
—
—
0
0
5
24
2.09
0.74
9.8
7.3
0.80
28.61
ug/l
—
5
17
5
25
2.01
0.73
1.4
1.3
—
—
—
0
0
14
206
0.67
0.72
1.1
1.1
0.81
0.89
g/l
0.77
14
206
17
240
0.70
0.71
1.6
1.5
—
—
—
0
0
52
429
1.23
0.70
2.5
2.1
—
—
—
0
0
7
41
1.72
0.70
1.1
1.7
—
—
—
0
0
9
59
1.53
0.68
1.8
1.8
—
—
—
0
0
5
27
1.86
0.68
1.4
1.3
—
—
—
0
0
5
29
1.73
0.64
1.0
1.1
1965.80
1666.59
miu/ml
—
5
29
5
29
1.73
0.64
1.4
1.5
2.40
1.83
u/field
—
5
22
134
1213
1.14
0.62
4.6
3.9
1.02
1.02
kg/l
0.65
94
803
0
20
0.00
0.60
0.0
1.1
—
24.79
—
0
20
6
37
1.63
0.55
2.0
2.0
0.79
0.70
e9/l
—
6
37
23
179
1.30
0.52
1.4
1.8
2.57
4.28
iu/l
—
8
68
14
191
0.73
0.51
1.5
1.6
55.87
59.05
ug/l
—
9
165
43
362
1.20
0.51
2.2
2.0
—
—
—
0
0
13
178
0.72
0.49
1.6
1.5
—
—
—
0
0
219
2066
1.10
0.49
4.6
3.7
0.00
0.02
estimate
1.56
59
476
36
419
0.85
0.39
1.7
1.8
3.73
3.46
mmol/l
0.78
23
306
6
43
1.40
0.35
3.0
2.3
—
—
—
0
0
30
348
0.85
0.32
1.5
1.6
1001.37
960.16
mu/l
0.11
24
299
8
67
1.20
0.26
1.5
1.4
—
—
—
0
0
8
67
1.20
0.26
1.5
1.4
—
—
—
0
0
51
560
0.90
0.26
2.0
2.0
3.60
3.46
ratio
0.26
40
446
5
71
0.70
0.26
1.0
1.5
9.34
7.37
mmol/l
—
5
58
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
1.29
—
0
6
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
15
173
0.86
0.17
2.4
2.0
—
—
—
0
0
8
68
1.18
0.16
1.5
1.4
—
—
—
0
0
8
71
1.13
0.16
1.5
1.4
—
—
—
0
0
11
92
1.20
0.16
1.9
1.5
—
—
—
0
0
8
72
1.11
0.16
1.5
1.4
—
—
—
0
0
8
72
1.11
0.16
1.5
1.4
—
—
—
0
0
11
93
1.19
0.14
7.4
2.1
19.98
4.55
umol/l
—
6
66
28
260
1.08
0.11
2.8
2.3
589.25
4715.67
u/l
—
8
106
16
176
0.91
0.09
1.6
1.7
—
—
—
0
0
5
48
1.04
0.09
1.6
1.2
—
—
—
0
0
156
1534
1.02
0.07
4.0
3.3
0.05
0.06
estimate
0.06
58
459
14
129
1.09
0.05
1.3
1.6
66.17
52.71
ug/l
0.88
14
129
20
204
0.98
0.00
1.5
1.9
—
—
—
0
0
14
143
0.98
0.00
1.8
1.8
—
—
—
0
0
16
162
0.99
0.00
1.9
1.8
—
—
—
0
0
29
292
0.99
0.00
1.0
1.1
—
—
—
0
0
7
77
0.91
0.00
1.7
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.19
—
0
6
7
76
0.92
-0.00
1.0
1.1
—
0.37
—
0
24
5
51
0.98
-0.00
1.4
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
11.44
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_ABNORMAL_FINDI_NIPPLE_DISCH_SYNOVIAL_FLUID_WOUND_SECRE – Abnormal findings in nipple discharge synovial fluid wound secretions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).